Broad Scope Aminocyclization of Enynes with Cationic JohnPhos-Gold(I) Complex as the Catalyst by R. Miller, J. Carreras, M. E. Muratore, et al.
Broad Scope Aminocyclization of Enynes with Cationic JohnPhos−
Gold(I) Complex as the Catalyst
Ricarda Miller,† Javier Carreras,† Michael E. Muratore,† Morgane Gaydou,† Francesco Camponovo,†
and Antonio M. Echavarren*,†,‡
†Institute of Chemical Research of Catalonia (ICIQ), Barcelona Institute of Science and Technology, Av. Països Catalans 16, 43007
Tarragona, Spain
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ABSTRACT: A practical aminocyclization of 1,6-enynes with a wide variety of substituted anilines, including N-alkyl anilines,
has been achived by using cationic [JohnPhosAu(MeCN)]SbF6 as a general purpose catalyst. The resulting adducts can be easily
converted into polycyclic compounds by palladium- and gold-catalyzed reactions.
1. INTRODUCTION
Gold(I) complexes are very active and selective catalysts for the
addition of nucleophiles on 1,n-enynes.1,2 The most emblem-
atic transformation in this area is the addition of alcohols and
water on 1,6-enynes 1 (alkoxy- or hydroxycyclization), which
occurs stereospecifically to form adducts 3 in the presence of
gold(I) catalysts3,4 under much milder conditions than with
other electrophilic metal catalysts (Scheme 1).5,6 According to
DFT calculations, this reaction proceeds through intermediates
2, whose structures are intermediate between cyclopropyl
gold(I) carbenes and gold(I)-stabilized homoallyl carboca-
tions.7 It is interesting to note that the hydroxycyclization is
usually much faster than the direct nucleophilic addition of
water on the terminal alkyne to form the corresponding methyl
ketone.8 Enantioselective hydroxy- and alkoxycyclizations of
1,6-enynes have been achieved with moderate to good
enantioselectivities with a variety of chiral phosphines or
NHC-gold catalysts.9 The hydroxy- and alkoxycyclizations of
1,5-4b,10,11 and 1,7-enynes take place similarly.12
A few examples of intramolecular amination of 1,5-enynes
have been described.10 The intermolecular reaction of 1,6-
enynes with carbamates ROCONH2 (R = Et, Bn) and anilines
also takes place using Ph3PAuCl and AgSbF6 (5 mol %).
13
However, in the latter case, only less basic anilines bearing
strongly electron-withdrawing groups (p-NO2, o-CN, o-CF3, p-
Cl) were used as the nucleophiles. We decided to study the
scope and limitations of the intermolecular amination of 1,6-
enynes with a broader range of anilines using gold(I) complexes
with JohnPhos and related bulky biphenyl-based phosphines
(Buchwald ligands), which are often the catalysts of choice in
gold(I)-catalyzed reactions.14
2. RESULTS AND DISCUSSION
The aminocyclization of enynes was initially studied with
dimethyl 2-trans-cinnamyl-2-(prop-2-yn-1-yl)malonate (1a) as
the substrate and a slight excess of the aniline using 2−5 mol %
of the gold catalyst in CH2Cl2 (Table 1). The best result for the
addition of aniline was obtained using 2 mol % of commercially
available cationic JohnPhos−gold(I) catalyst A, leading to
adduct 4a in excellent yield (Table 1, entry 1). Increasing the
catalyst loading to 5 mol % was required for the addition of p-
anisidine to form 4b in 58% yield after a 19 h reaction time
(Table 1, entry 2). This result with an electron-rich aniline is
remarkable since this reaction had only been reported with
deactivated amines.13 Lower yields were obtained with gold(I)
complexes with other phosphine, NHC, or phosphite ligands
(Table 1, entries 3−7). Tetrahydrofuran was also evaluated as
solvent in the reaction with aniline; however, the yield was
significantly reduced.15
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Scheme 1. Gold(I)-Catalyzed Alkoxy- or Hydroxycyclization
of 1,6-Enynes
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It is important to note that the reaction of anilines and
aliphatic amines with complex A forms complexes
[(JohnPhos)Au(NH2R)]SbF6 by ligand substitution, which
have been characterized by X-ray diffraction and show
diminished catalytic activity in the reaction of cyclopropenes
with p-anisidine.16 However, in our system, these less active
amino complexes presumably formed in situ under the
amination reaction still undergo ligand exchange with the
enynes at a sufficient rate so as to generate the catalytically
active (η2-alkyne)gold(I) species.15
The substrate generality under these reaction conditions was
tested with different enynes and a wide range of anilines (Table
2). In general, moderate to excellent yields were obtained for
the different combinations of 1,6-enynes and anilines examined
(42−98%). Concerning the anilines, electron-rich as well as
electron-poor anilines participated efficiently in this reaction
without significant differences in the isolated yields. Anilines
substituted at the ortho-position also gave rise to the
corresponding adducts 4c, 4e, 4h, 4o, 4w, and 4y in satisfactory
yields. Secondary anilines, such as N-methylaniline, N-allylani-
line, indoline, or tetrahydroquinoline also reacted to give the
corresponding adducts in moderate to good yields (4l, 4t, 4ad−
ag). Different substitution patterns on the enyne were also
used, and all led efficiently to the desired product. The presence
of a dimethyl or phenyl substituent on the alkene did not give
significantly different results in terms of reactivity. The relative
configuration of the aminocyclization products was assigned by
determining the structures of compounds 4d, 4i, and 4x by X-
ray crystallography analysis,17 confirming the anti-type addition
of the nucleophile to the 1,6-enyne.
To illustrate the synthetic potential of this gold(I) catalyzed
reaction, additional transformations were carried out on several
halogenated derivatives, in order to increase the molecular
complexity. First, an intramolecular Heck reaction was
successfully applied for compounds bearing iodine in the
ortho position (Scheme 2, 4e−g). Under standard conditions,
good yields of the desired cis-fused tricyclic structures 5e−g
were obtained after selective 6-exo cyclization. This outcome
represents an easy access to these tetrahydro-1H-cyclopenta-
[c]quinoline derivatives. The use of o-Br derivative 4c or
dimethyl substituted compound 4y only led to the recovery of
the starting material. It is interesting to note that the initial
Table 1. Gold(I)-Catalyzed Aminocyclization of 1,6-Enyne
1a
entry Ar [Au], mol %
time
(h)
product, yield
(%)a
1 Ph A (2) 16 4a (95a, 93b)
2 p-MeOC6H4 A (5) 19 4b (58)
3 p-MeOC6H4 B (5) 19 4b (42)
4 p-MeOC6H4 C (5) 19 4b (30)
5 p-MeOC6H4 D1 (5) 19 4b (10)
6 p-MeOC6H4 E (5) 19 4b (23)
7 p-MeOC6H4 PPh3AuCl/AgSbF6
(5)
19 4b (7b)
aYields determined by 1H NMR. bIsolated yield.
Table 2. Gold(I)-Catalyzed Aminocyclization of 1,6-Enynes
1a−f with Different Anilines
a5 mol % catalyst.
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alkyl-palladium(II) species of the Heck reaction evolves by an
intramolecular redox process presumably via β-hydride
elimination from the benzylic position of cationic intermediate
Int(4−5), followed by reductive elimination.
Then, we envisioned a second gold-catalyzed aminocycliza-
tion to form N-substituted indoles (Scheme 2). The alkyne was
introduced at the ortho position by Sonogashira cross-coupling
of the iodoarenes with trimethylsilylacetylene to form 6e−g in
near-quantitative yields, followed by deprotection of the TMS-
alkynyl compounds by methanolysis to give 7e−g. The new
gold(I)-catalyzed aminocyclization proceeded efficiently using
catalyst D2 with IPr as the NHC ligand, leading to indole
derivatives 8e−g in good yields. The presence of chlorine or
bromine atoms in 5f−g and 8f−g could allow their further
functionalizations by cross-coupling reactions or other
tranformations.
3. CONCLUSIONS
Although amines coordinate to Lewis acidic gold(I) complexes,
thus reducing their availability to activate alkynes and other
substrates, robust cationic gold(I) complex [JohnPhosAu-
(MeCN)]SbF6 is the catalyst of choice for the broad-scope
aminocyclization of 1,6-enynes. The reaction proceeds under
mild conditions in moderate to excellent yields with a wide
variety of substituted anilines, including electron-rich as well as
secondary N-alkyl anilines to give the corresponding adducts,
which can be further derivatized to form polycyclic compounds
by palladium- and gold-catalyzed reactions.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Solvents were dried by
passing through an activated alumina column on a solvent purification
system. Analytical thin layer chromatography was carried out using
TLC-aluminum sheets with 0.2 mm of silica gel (Merck GF254) using
UV light as the visualizing agent or an acidic solution of vanillin in
ethanol as the developing agent. Purifications by chromatography were
carried out using flash grade silica gel (SDS Chromatogel 60 ACC,
40−60 mm). Preparative TLC was performed on 20 cm × 20 cm silica
gel plates (2.0 mm thick, catalogue number 02015, Analtech). Organic
solutions were concentrated under reduced pressure on a rotary
evaporator. Unless otherwise stated, NMR spectra were recorded at
298 K on 300, 400, and 500 MHz devices. 1H and 13C chemical shifts
(δ) are given in ppm relative to TMS, and coupling constants (J), in
Hz. The solvent signals were used as references, and the chemical
shifts were converted to the TMS scale. Mass spectra were recorded
employing TOF mass analyzers (ESI, EI, CI). Melting points were
determined by observation of the fusion of the solids placed in a
capillary, through a magnifying glass. Crystal structure determinations
were carried out using a diffractomer equipped with an APPEX 2 4K
CCD area detector, an FR591 rotating anode with Mo Kα radiation,
Montel mirrors as the monochromator, and a Kryoflex low
temperature device (T = −173 °C). Full-sphere data collection was
used with w and j scans. Programs used: Data collection APEX-2, data
reduction Bruker Saint V/.60A and absorption correction SADABS.
Structure Solution and Refinement: Crystal structure solution was
achieved using direct methods as implemented in SHELXTL and
visualized using the program XP. Missing atoms were subsequently
located from difference Fourier synthesis and added to the atom list.
Least-squares refinement on F2 using all measured intensities was
carried out using the program SHELXTL. All non-hydrogen atoms
were refined including anisotropic displacement parameters.
Compounds 1a,18 1b,19 and 1c19 were prepared according to
reported methods. Gold complexes A, B, and C are commercialy
available; D1,
2 D2,
4c and E2 were prepared according to literature
procedures.
2-Cinnamyl-2-(prop-2-yn-1-yl)propane-1,3-diol. LiAlH4 (461 mg,
12.1 mmol) was suspended in anhydrous THF (30 mL), and the slurry
was cooled to 0 °C. A solution of malonate 1a (1.58 g, 5.52 mmol) in
anhydrous THF (2 mL) was added dropwise at 0 °C. When
effervescence had ceased, the mixture was allowed to warm to room
temperature and was then heated at 45 °C and stirred vigorously for
3.5 h. TLC (c-hexane/EtOAc 8:1 and 1:1) showed full consumption of
the starting malonate and clean conversion. The mixture was diluted
with wet diethyl ether (30 mL) and quenched by addition of sodium
sulfate decahydrate (ca. 2 g) slowly, to control the effervescence. After
stirring for 1 h at rt, a few drops of saturated aqueous NH4Cl were
added, until the suspension became white. The solids were filtered off
over Celite, and the cake was washed thoroughly with diethyl ether
(200 mL). The filtrate was concentrated in vacuo, and the residue was
purified by column chromatography on silica gel eluting with pentane/
diethyl ether 1:1 to straight diethyl ether to afford 1.15 g of a colorless
solid (90%). 1H NMR (500 MHz, CDCl3) δ 7.39−7.35 (m, 2H),
7.34−7.29 (m, 2H), 7.25−7.21 (m, 1H), 6.50 (d, J = 15.6 Hz, 1H),
6.23 (dt, J = 15.6, 7.7 Hz, 1H), 3.76−3.67 (m, 4H), 2.43−2.37 (m,
2H), 2.33 (dd, J = 7.7, 1.4 Hz, 2H), 2.32 (d, J = 2.8 Hz, 2H), 2.08 (t, J
= 2.7 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 137.2, 133.6,
128.5, 127.3, 126.1, 124.8, 80.9, 71.0, 67.5, 42.7, 35.2, 21.6 ppm.
HRMS-APCI calcd for C15H19O2
+ [M + H]+: 231.1380; found:
231.1386. Mp 100−102 °C.
5-Cinnamyl-2,2-dimethyl-5-(prop-2-yn-1-yl)-1,3-dioxane (1d). In
a dry flask, 2-cinnamyl-2-(prop-2-yn-1-yl)propane-1,3-diol (600 mg,
2.61 mmol) was dissolved in anhydrous acetone (2 mL) and pTsOH·
H2O (25 mg, 0.13 mmol) was added, followed by addition of MgSO4
(300 mg). The suspension was stirred vigorously at rt for 24 h. TLC
showed clean conversion to a new product and only traces of starting
material. Acetone was removed under a stream of nitrogen, and the
mixture was loaded on silica gel and purified by column
chromatography eluting with pentane/diethyl ether 95:5 to 9:1 to
Scheme 2. Transformation of Adducts 4e−g into
Tetrahydro-1H-cyclopenta[c]quinoline and Indole
Derivatives via Pd(0)-Catalyzed Cross-Coupling and Au(I)-
Catalyzed Cyclization
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afford 650 mg of a colorless oil (92%). Remark: melting point close to
room temperature. 1H NMR (500 MHz, CDCl3) δ 7.39−7.35 (m,
2H), 7.35−7.30 (m, 2H), 7.26−7.21 (m, 1H), 6.51 (d, J = 15.8 Hz,
1H), 6.19 (dt, J = 15.6, 7.7 Hz, 1H), 3.73 (s, 4H), 2.42 (d, J = 2.8 Hz,
2H), 2.37 (dd, J = 7.8, 1.3 Hz, 2H), 2.08 (t, J = 2.7 Hz, 1H), 1.46 (s,
3H), 1.44 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 137.2, 133.9,
128.5, 127.3, 126.1, 124.0, 98.2, 80.6, 71.1, 66.7, 36.1, 36.0, 25.3, 22.5,
22.2 ppm. HRMS-ESI calcd for C18H22O2Na
+ [M + Na]+: 293.1512;
found: 293.1512.
(E)-(4,4-Bis(methoxymethyl)hept-1-en-6-yn-1-yl)benzene (1e).20
In a dry flask, 2-cinnamyl-2-(prop-2-yn-1-yl)propane-1,3-diol (200
mg, 0.87 mmol) was dissolved in anhydrous THF (2 mL), and NaH
(80 mg, 2 mmol), MeI (135 mL, 2.17 mmol), and TBAI (48 mg, 0.13
mmol) were added sequentially. The suspension was stirred vigorously
at rt for 24 h. TLC showed full consumption of starting material and
conversion to diprotected alcohol with traces of monoprotection. The
mixture was quenched by careful addition of saturated aqueous NH4Cl
(30 mL) and extracted with diethyl ether (3 × 50 mL). The combined
organic layers were washed with brine (2 × 15 mL), dried over
MgSO4, and filtered, and the solvent was removed under vacuum. The
resulting mixture was purified by column chromatography on silica gel
eluting with c-hexane/EtOAc 10:1 to afford 210 mg of a colorless oil
(94%). 1H NMR (500 MHz, CDCl3) δ 7.39−7.35 (m, 2H), 7.34−7.29
(m, 2H), 7.25−7.20 (m, 1H), 6.47 (d, J = 15.8 Hz, 1H), 6.23 (dt, J =
15.6, 7.7 Hz, 1H), 3.36 (s, 6H), 3.34−3.28 (m, 4H), 2.34 (dd, J = 7.7,
1.3 Hz, 2H), 2.27 (d, J = 2.7 Hz, 2H), 2.02 (t, J = 2.7 Hz, 1H) ppm.
13C NMR (126 MHz, CDCl3) δ 137.7, 133.1, 128.5, 127.0, 126.1,
125.7, 81.3, 74.3, 70.1, 59.3, 42.4, 35.4, 22.2 ppm. HRMS-APCI calcd
for C17H23O2
+ [M + H]+: 259.1693; found: 259.1690.
4,4′-(((2-Cinnamyl-2-(prop-2-yn-1-yl)propane-1,3diyl)bis(oxy))-
bis(methylene)) Bis(methoxybenzene) (1f).20 In a dry flask, 2-
cinnamyl-2-(prop-2-yn-1-yl)propane-1,3-diol (200 mg, 0.87 mmol)
was dissolved in anhydrous THF (2 mL), and NaH (73 mg, 1.82
mmol), PMB-Cl (0.26 mL, 1.91 mmol), and TBAI (48 mg, 0.13
mmol) were added sequentially. The suspension was stirred vigorously
at rt for 24 h. TLC showed full consumption of starting material and
conversion to mono- and diprotected alcohols (diprotection major).
The mixture was quenched by careful addition of saturated aqueous
NH4Cl (30 mL) and extracted with diethyl ether (3 × 50 mL). The
combined organic layers were washed with brine (2 × 15 mL), dried
over MgSO4, and filtered, and the solvent was removed under vacuum.
The resulting mixture was purified by column chromatography on
silica gel eluting with c-hexane/EtOAc 10:1 to afford 230 mg of a
colorless oil (64%). 1H NMR (500 MHz, CDCl3) δ 7.34−7.23 (m,
8H), 7.23−7.18 (m, 1H), 6.89−6.84 (m, 4H), 6.39 (d, J = 15.7 Hz,
1H), 6.12 (dt, J = 15.6, 7.7 Hz, 1H), 4.45 (s, 4H), 3.81 (s, 6H), 3.42−
3.36 (m, 4H), 2.35 (dd, J = 7.7, 1.3 Hz, 2H), 2.31 (d, J = 2.7 Hz, 2H),
1.98 (t, J = 2.7 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 159.0,
137.7, 132.9, 130.8, 129.1, 128.4, 126.9, 126.1, 125.9, 113.7, 81.4, 72.9,
71.4, 70.2, 55.2, 42.6, 35.4, 22.4 ppm. HRMS-ESI calcd for
C31H34O4Na
+ [M + Na]+: 493.2349; found: 493.2362.
General Procedure for the Aminocyclization of 1,6-Enynes
(GP-I). Enyne (1 equiv) and aniline (1.1 equiv) were placed in a dry
flask, and [JohnPhosAu(MeCN)]SbF6 (A) (2 mol %) was added as a
solution in anhydrous CH2Cl2 (overall 0.15 M). The solution was
stirred vigorously at rt for 16 h.
Dimethyl 3-Methylene-4-(phenyl(phenylamino)methyl)cyclo-
pentane-1,1-dicarboxylate (4a). Obtained using catalyst A (2.2 mg,
2.8 μmol), enyne 1a (0.14 mL, 1.0 M in dry CH2Cl2, 0.14 mmol), and
aniline (0.30 mL, 0.5 M in dry CH2Cl2, 0.154 mmol) as the
nucleophile in CH2Cl2 (0.6 mL) according to General Procedure I.
Preparative TLC (c-hexane/EtOAc 5:1) yielded 49 mg (93%) of the
aminated product as a colorless oil. 1H NMR (400 MHz, CDCl3) δ
7.41−7.40 (m, 2H), 7.39−7.36 (m, 2H), 7.26 (tt, J = 4.2, 1.5 Hz, 1H),
7.10 (dd, J = 8.6, 7.4 Hz, 2H), 6.67 (tt, J = 7.4, 1.2 Hz, 1H), 6.54 (dd, J
= 8.6, 1.2 Hz, 2H), 5.10−5.08 (m, 1H), 4.80−4.78 (m, 1H), 4.57 (d, J
= 5.0 Hz, 1H), 4.34 (s, 1H), 3.78 (s, 3H), 3.71 (s, 3H), 3.16−3.07 (m,
2H), 3.01−2.96 (m, 1H), 2.39−2.33 (m, 1H), 2.28−2.24 (m, 1H)
ppm. 13C NMR (101 MHz, CDCl3) δ 172.4, 171.8, 147.8, 147.2,
142.3, 129.0, 128.5, 127.0, 126.7, 117.5, 113.7, 109.1, 59.0, 58.2, 52.9,
52.8, 49.4, 42.0, 34.9 ppm. HRMS-ESI calcd for C23H26NO4
+ [M +
H]+: 380.1856; found: 380.1865.
Dimethyl 3-(((4-Methoxyphenyl)amino)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (4b). Obtained using
catalyst A (5.6 mg, 7.4 μmol), enyne 1a (42 mg, 0.15 mmol) and p-
anisidine (19 mg, 0.16 mol) as the nucleophile in CH2Cl2 (1.0 mL)
according to the General Procedure I. Purification by column
chromatography (n-hexane/EtOAc 9:1) yielded 28 mg (47%) of the
aminated product as a yellow oil. 1H NMR (400 MHz, CDCl3) δ
7.38−7.18 (m, 5H), 6.70−6.65 (m, 2H), 6.47−6.42 (m, 2H), 5.06 (br
s, 1H), 4.77 (br s, 1H), 4.44 (d, J = 4.6 Hz, 1H), 3.98 (s, 1H), 3.73 (s,
3H), 3.67 (s, 6H), 3.20−2.95 (m, 3H), 2.32 (dd, J = 13.6, 9.8 Hz, 1H),
2.23 (dd, J = 13.6, 8.7 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ
172.4, 172.0, 152.2, 147.6, 142.6, 142.2, 128.7, 127.1, 126.9, 115.1,
114.8, 109.1, 60.0, 57.9, 55.8, 53.0, 52.9, 49.7, 42.1, 35.0 ppm. HRMS-
ESI calcd for C24H28NO5
+ [M + H]+: 410.1962; found: 410.1984.
Dimethyl 3-(((2-Bromophenyl)amino)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (4c). Obtained using
catalyst A (2.2 mg, 2.8 μmol), enyne 1a (0.14 mL, 1.0 M in dry
CH2Cl2, 0.14 mmol), and 2-bromoaniline (26 mg, 0.15 mmol) as the
nucleophile in CH2Cl2 (0.85 mL) according to General Procedure I.
Preparative TLC (c-hexane/EtOAc 5:1) yielded 56 mg (87%) of the
aminated product as a colorless oil. 1H NMR (400 MHz, CDCl3) δ
7.41 (dd, J = 7.9, 1.4 Hz, 1H), 7.35−7.31 (m, 4H), 7.27−7.24 (m,
1H), 6.99 (dt, J = 7.6, 1.4 Hz, 1H), 6.53 (dt, J = 7.6, 1.4 Hz, 1H), 6.36
(dd, J = 7.6, 1.4 Hz, 1H), 5.09 (m, 1H), 4.80 (d, J = 4.7 Hz, 1H), 4.72
(m, 1H), 4.52 (t, J = 5.3 Hz, 1H), 3.74 (s, 3H), 3.71 (s, 3H), 3.18−
3.16 (m, 1H), 3.03 (s, 2H), 2.45 (dd, J = 13.7, 8.2 Hz, 1H), 2.29 (dd, J
= 13.7, 9.9 Hz, 1H) ppm. 13C NMR (101 MHz, CDCl3) δ 171.8,
171.7, 146.9, 144.3, 141.2, 132.2, 128.5, 128.2, 127.3, 126.8, 118.1,
112.9, 110.3, 109.9, 60.3, 58.1, 52.9, 52.8, 49.4, 42.1, 35.5 ppm.
HRMS-ESI calcd for C23H25BrNO4
+ [M + H]+: 458.0961; found:
458.0969.
Dimethyl 3-(((4-Bromophenyl)amino)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (4d). Obtained using
catalyst A (5.7 mg, 7.4 μmol), enyne 1a (42 mg, 0.15 mmol), and
4-bromoaniline (31 mg, 0.18 mol) as the nucleophile in CH2Cl2 (1.0
mL) according to General Procedure I. Purification by column
chromatography (pentane/diethyl ether 9:1 to 4:1) yielded 50 mg
(74%) of the aminated product as a white solid, which was further
crystallized from Et2O/pentane.
1H NMR (400 MHz, CDCl3) δ 7.40−
7.22 (m, 5H), 7.18−7.14 (m, 2H), 6.43−6.36 (m, 2H), 5.08 (br s,
1H), 4.78 (br s, 1H), 4.55−4.50 (m, 2H), 3.78 (s, 3H), 3.71 (s, 3H),
3.14−3.05 (m, 2H), 2.99−2.92 (m, 1H), 2.35 (dd, J = 14.0, 9.3 Hz,
1H), 2.21 (dd, J = 14.0, 9.3 Hz, 1H) ppm. 13C NMR (101 MHz,
CDCl3) δ 172.7, 171.9, 147.2, 146.9, 141.9, 131.8, 128.8, 127.3, 126.7,
115.3, 109.2, 109.1, 58.9, 57.7, 53.1, 52.9, 49.3, 42.2, 34.7 ppm.
HRMS-ESI calcd for C23H25BrNO4
+ [M + H]+: 458.0961; found:
458.0971. Mp 124−126 °C.
Dimethyl 3-(((2-Iodophenyl)amino)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (4e). Obtained using
catalyst A (15 mg, 20 μmol), enyne 1a (286 mg, 1 mmol), and 2-
iodoaniline (234 mg, 1.07 mmol) as the nucleophile in CH2Cl2 (4
mL) according to General Procedure I. Purification by column
chromatography (pentane/diethyl ether 9:1 to 4:1) yielded 489 mg
(98%) of the aminated product as a colorless solid. Note: on 2.79
mmol scale, the reaction afforded the desired compound in 90% yield.
1H NMR (500 MHz, CDCl3) δ 7.64 (dd, J = 7.8, 1.5 Hz, 1H), 7.36−
7.30 (m, 4H), 7.28−7.22 (m, 1H), 7.00 (ddd, J = 8.2, 6.8, 1.5 Hz, 1H),
6.39 (ddd, J = 7.8, 7.3, 1.5 Hz, 1H), 6.27 (dd, J = 8.2, 1.5 Hz, 1H), 5.10
(q, J = 2.2 Hz, 1H), 4.76 (q, J = 2.2 Hz, 1H), 4.61 (d, J = 4.6 Hz, 1H),
4.52 (t, J = 5.1 Hz, 1H), 3.73 (s, 3H), 3.70 (s, 3H), 3.16 (dtt, J = 12.3,
5.5, 2.3 Hz, 1H), 3.11−2.99 (m, 2H), 2.42 (ddd, J = 13.7, 8.1, 1.4 Hz,
1H), 2.28 (dd, J = 13.7, 10.1 Hz, 1H) ppm. 13C NMR (126 MHz,
CDCl3) δ 171.8, 171.7, 147.0, 146.4, 141.1, 138.8, 129.1, 128.6, 127.3,
126.8, 119.0, 112.2, 110.0, 86.2, 60.7, 58.2, 52.9, 52.8, 49.5, 42.1, 35.5
ppm. HRMS-ESI calcd for C23H24INO4Na
+ [M + Na]+: 528.0642,
found 528.0637. Mp 129−131 °C.
Dimethyl 3-(((4-Bromo-2-iodophenyl)amino)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (4f). Obtained using
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catalyst A (19 mg, 24 μmol), enyne 1a (350 mg, 1.22 mmol), and 4-
bromo-2-iodoaniline (401 mg, 1.35 mmol) as the nucleophile in
CH2Cl2 (8 mL) according to General Procedure I. Purification by
column chromatography (pentane/Et2O 9:1) yielded 644 mg (90%)
of the aminated product as a white solid. 1H NMR (500 MHz, CDCl3)
δ 7.72 (d, J = 2.3 Hz, 1H), 7.35−7.21 (m, 5H), 7.07 (dd, J = 8.7, 2.3
Hz, 1H), 6.11 (d, J = 8.7 Hz, 1H), 5.10 (q, J = 2.2 Hz, 1H), 4.74 (q, J
= 2.2 Hz, 1H), 4.61 (d, J = 4.5 Hz, 1H), 4.47 (t, J = 5.0 Hz, 1H), 3.72
(s, 3H), 3.69 (s, 3H), 3.18−3.11 (m, 1H), 3.03 (bs, 2H), 2.39 (dd, J =
13.7, 8.2 Hz, 1H), 2.24 (dd, J = 13.7, 10.2 Hz, 1H) ppm. 13C NMR
(126 MHz, CDCl3) δ 171.9, 171.8, 147.1, 145.8, 140.7, 140.3, 132.0,
128.8, 127.7, 126.9, 113.3, 110.3, 109.4, 86.3, 60.9, 58.3, 53.1, 53.0,
49.5, 42.3, 35.6 ppm. HRMS-ESI calcd for C23H23BrINO4Na
+ [M +
Na]+: 605.9747; found: 605.9747. Mp 123−125 °C.
Dimethyl 3-(((5-Chloro-2-iodophenyl)amino)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (4g). Obtained using
catalyst A (19 mg, 24 μmol), enyne 1a (350 mg, 1.22 mmol), and
5-chloro-2-iodoaniline (341 mg, 1.35 mmol) as the nucleophile in
CH2Cl2 (8 mL) according to General Procedure I. Purification by
column chromatography (pentane/Et2O 9:1) yielded 562 mg (85%)
of the aminated product as a white solid. 1H NMR (500 MHz, CDCl3)
δ 7.51 (d, J = 8.3 Hz, 1H), 7.37−7.29 (m, 4H), 7.28−7.23 (m, 1H),
6.39 (dd, J = 8.3, 2.3 Hz, 1H), 6.24 (d, J = 2.3 Hz, 1H), 5.09 (q, J = 2.1
Hz, 1H), 4.73 (q, J = 2.2 Hz, 1H), 4.68 (d, J = 5.0 Hz, 1H), 4.49 (t, J =
5.3 Hz, 1H), 3.72 (s, 3H), 3.69 (s, 3H), 3.20−3.12 (m, 1H), 3.05−2.99
(m, 2H), 2.42 (dd, J = 13.7, 8.1 Hz, 1H), 2.23 (dd, J = 13.7, 10.1 Hz,
1H) ppm. 13C NMR (126 MHz, CDCl3) δ 171.9, 171.8, 147.5, 147.0,
140.5, 139.4, 135.4, 128.9, 127.7, 126.9, 119.1, 112.2, 110.3, 83.2, 60.7,
58.3, 53.1, 53.0, 49.4, 42.3, 35.6 ppm. HRMS-ESI calcd for
C23H23ClINO4Na
+ [M + Na]+: 562.0253; found: 562.0262. Mp
143−145 °C.
Dimethyl 3-((Mesitylamino)(phenyl)methyl)-4-methylenecyclo-
pentane-1,1-dicarboxylate (4h). Obtained using catalyst A (2.2 mg,
2.8 μmol), enyne 1a (0.14 mL, 1.0 M in dry CH2Cl2, 0.14 mmol), and
2,4,6-trimethylaniline (0.31 mL, 0.5 M in CH2Cl2, 0.15 mmol) as the
nucleophile in CH2Cl2 (0.6 mL) according to General Procedure I.
Preparative TLC (c-hexane/EtOAc 5:1) yielded 48 mg (82%) of the
aminated product as a colorless oil. 1H NMR (400 MHz, CDCl3) δ
7.21−7.14 (m, 5H), 6.68 (s, 2H), 4.86 (d, J = 1.7 Hz, 1H), 4.36 (d, J =
1.7 Hz, 1H), 4.22 (d, J = 8.4 Hz, 1H), 3.77 (s, 3H), 3.75 (s, 3H), 3.45
(s, 1H), 3.29−3.25 (m, 1H), 2.98−2.87 (m, 3H), 2.42 (dd, J = 13.8,
9.5 Hz, 1H), 2.16 (s, 3H), 2.10 (s, 6H) ppm. 13C NMR (101 MHz,
CDCl3) δ 172.2, 172.0, 148.2, 142.8, 141.5, 130.2, 129.6, 128.4, 128.0,
127.4, 127.0, 110.0, 64.0, 58.1, 52.9, 52.8, 47.9, 42.2, 37.8, 20.4, 19.3
ppm. HRMS-ESI calcd for C26H32NO4
+ [M + H]+: 422.2326; found:
422.2331.
Dimethyl 3-(((3,5-Bis(trifluoromethyl)phenyl)amino)(phenyl)-
methyl)-4-methylenecyclopentane-1,1-dicarboxylate (4i). Obtained
using catalyst A (5.7 mg, 7.4 μmol), enyne 1a (41 mg, 0.14 mmol) and
3,5-bistrifluoromethylaniline (25 μL, 0.16 mol) as the nucleophile in
CH2Cl2 (1.0 mL) according to General Procedure I. Purification by
column chromatography (c-hexane/EtOAc 12:1) yielded 67 mg
(89%) of the aminated product as a white solid. 1H NMR (400
MHz, CDCl3) δ 7.36−7.30 (m, 4H), 7.30−7.23 (m, 1H), 7.07 (br s,
1H), 6.85−6.81 (m, 2H), 5.27 (d, J = 4.6 Hz, 1H), 5.10−5.05 (m,
1H), 4.79−4.76 (m, 1H), 4.62 (dd, J = 4.6 Hz, 1H), 3.78 (s, 3H), 3.69
(s, 3H), 3.20−3.13 (m, 1H), 3.13−3.08 (m, 1H), 2.93−2.86 (m, 1H),
2.39 (dd, J = 14.2, 8.5 Hz, 1H), 2.18 (dd, J = 14.6, 10.4 Hz, 1H) ppm.
13C NMR (101 MHz, CDCl3) δ 173.2, 171.7, 148.6, 147.0, 140.7,
132.2 (q, J = 32.9 Hz), 129.1, 127.8, 126.6, 123.6 (q, J = 273.4 Hz),
112.7, 110.3 (sept, J = 4.1 Hz), 109.2, 58.4, 57.6, 53.4, 53.0, 48.8, 42.4,
34.4 ppm. 19F NMR (376.49 MHz, CDCl3) δ −63.0 ppm. HRMS-ESI
calcd for C25H23F6NO4Na
+ [M + Na]+: 538.1423; found: 538.1437.
Mp 143−145 °C.
Dimethyl 3-Methylene-4-((naphthalen-1-ylamino)(phenyl)-
methyl)cyclopentane-1,1-dicarboxylate (4j). Obtained using catalyst
A (2.2 mg, 2.8 μmol), enyne 1a (0.14 mL, 1.0 M in dry CH2Cl2, 0.14
mmol), and naphtalen-1-amine (20 mg, 0.14 mmol) as the nucleophile
in CH2Cl2 (0.8 mL) according to General Procedure I. Preparative
TLC (c-hexane/EtOAc 5:1) yielded 31 mg (51%) of the aminated
product as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 8.10 (br d, J
= 7.9 Hz, 1H), 7.80 (dd, J = 7.6, 1.8 Hz, 1H), 7.54−7.44 (m, 4H), 7.34
(t, J = 7.2 Hz, 2H), 7.28−7.24 (m, 1H), 7.21−7.14 (m, 2H), 6.33 (dd,
J = 7.2, 1.2 Hz, 1H), 5.09 (d, J = 2.2 Hz, 1H), 4.85 (d, J = 2.2 Hz, 1H),
4.80 (d, J = 4.7 Hz, 1H), 3.82 (s, 3H), 3.73 (s, 3H), 3.32−3.28 (m,
1H), 3.15 (d, J = 16.2 Hz, 1H), 3.02 (dd, J = 16.2, 1.9 Hz, 1H), 2.58
(dd, J = 14.0, 9.6 Hz, 1H), 2.30 (dd, J = 14.0, 9.6 Hz, 1H) ppm. 13C
NMR (101 MHz, CDCl3) δ 172.5, 171.8, 147.2, 142.6, 141.9, 134.2,
128.6, 127.1, 126.6, 126.4, 125.6, 124.7, 123.9, 120.2, 117.5, 109.1,
106.4, 58.7, 57.6, 52.9, 52.7, 49.4, 42.3, 34.7 ppm. HRMS-ESI calcd for
C27H28NO4
+ [M + H]+: 430.2013; found: 430.2020.
Dimethyl 3-Methylene-4-(phenyl(quinolin-8-ylamino)methyl)-
cyclopentane-1,1-dicarboxylate (4k). Obtained using catalyst A
(2.2 mg, 2.8 μmol), enyne 1a (0.14 mL, 1.0 M in dry CH2Cl2, 0.14
mmol), and quinolin-8-amine (20 mg, 0.14 mmol) as the nucleophile
in CH2Cl2 (0.8 mL) according to General Procedure I. Preparative
TLC (c-hexane/EtOAc 5:1) yielded 28 mg (46%) of the aminated
product as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 8.79 (dd, J =
4.0, 1.6 Hz, 1H), 8.05 (dd, J = 8.0, 1.6 Hz, 1H), 7.43 (d, J = 8.4 Hz,
2H), 7.38 (dd, J = 8.0, 4.0 Hz, 1H), 7.32 (t, J = 7.2 Hz, 2H), 7.24−7.19
(m, 2H), 7.01 (dd, J = 8.4, 0.8 Hz, 1H), 6.78 (d, J = 6.0 Hz, 1H), 6.45
(dd, J = 7.6, 0.8 Hz, 1H), 5.01 (d, J = 2.0 Hz, 1H), 4.62 (t, J = 6.4 Hz,
1H), 4.58 (d, J = 2.0 Hz, 1H), 3.74 (s, 3H), 3.73 (s, 3H), 3.29−3.25
(m, 1H), 3.13 (qd, J = 16.4, 2.4 Hz, 1H), 3.01 (qd, J = 16.4, 2.4 Hz,
1H), 2.63 (ddd. J = 14.0, 9.6, 1.6, Hz, 1H), 2.39 (dd, J = 14.0, 9.6 Hz,
1H) ppm. 13C NMR (101 MHz, CDCl3) δ 171.9, 171.8, 147.1, 147.0,
143.9, 142.0, 138.4, 135.9, 128.5, 128.4, 127.5, 127.2, 127.1, 121.3,
114.2, 109.9, 106.2, 60.3, 58.4, 52.8, 49.4, 41.9, 36.2 ppm. HRMS-ESI
calcd for C26H27N2O4
+ [M + H]+: 431.1965; found: 431.1954.
Dimethyl 3-((Methyl(phenyl)amino)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (4l). Obtained using
catalyst A (2.2 mg, 2.8 μmol), enyne 1a (0.14 mL, 1.0 M in dry
CH2Cl2, 0.14 mmol), and N-methylaniline (0.3 mL, 0.5 M in dry
CH2Cl2, 0.15 mmol) as the nucleophile in CH2Cl2 (0.6 mL) according
to General Procedure I. Preparative TLC (c-hexane/EtOAc 5:1)
yielded 50 mg (92%) of the aminated product as a colorless oil. 1H
NMR (400 MHz, CDCl3) δ 7.27−7.23 (m, 7H), 6.89−6.86 (m, 2H),
6.75 (tt, J = 7.2, 1.0 Hz, 1H), 4.86−4.81 (m, 2H), 4.22 (d, J = 2.1 Hz,
1H), 3.79 (s, 3H), 3.70 (s, 3H), 3.60−3.57 (m, 1H), 3.24 (qd, J = 16.5,
2.1 Hz, 1H), 3.01 (dd, J = 16.6, 2.1 Hz, 1H), 2.74 (ddd, J = 13.5, 7.7,
1.5 Hz, 1H), 2.67 (s, 3H), 2.12 (dd, J = 13.5, 9.9 Hz, 1H) ppm. 13C
NMR (101 MHz, CDCl3) δ 172.4, 171.9, 150.1, 148.6, 138.9, 129.2,
128.1, 128.0, 127.3, 117.3, 113.9, 109.8, 65.7, 57.6, 52.9, 52.8, 43.4,
41.8, 38.6, 31.8 ppm. HRMS-ESI calcd for C24H28NO4
+ [M + H]+:
394.2013; found: 394.2026.
N-(2-(2-Methylene-4,4-bis(phenylsulfonyl)cyclopentyl)propan-2-
yl)aniline (4m). Obtained using catalyst A (1.9 mg, 2.5 μmol), enyne
1b (0.12 mL, 1.0 M in dry CH2Cl2, 0.12 mmol), and aniline (0.25 mL,
0.5 M in CH2Cl2, 0.124 mmol) as the nucleophile in CH2Cl2 (0.6 mL)
according to General Procedure I. Preparative TLC (c-hexane/EtOAc
5:1) yielded 58 mg (94%) of the aminated product as a colorless oil.
1H NMR (400 MHz, CDCl3) δ 8.09 (dd, J = 6.4, 0.8 Hz, 2H), 7.97
(dd, J = 5.6, 0.8 Hz, 2H), 7.75−7.69 (m, 2H), 7.62 (t, J = 6.0 Hz, 2H),
7.54 (t, J = 6.4 Hz, 2H), 7.19 (dd, J = 6.8, 6.0 Hz, 2H), 6.81 (t, J = 6.0
Hz, 2H), 6.68 (dd, J = 7.2, 6.8 Hz, 1H), 5.02 (br s, 2H), 3.63 (br s,
1H), 3.55 (qd, J = 14.0, 2.0 Hz, 1H), 3.35 (dt, J = 14.0, 2.0 Hz, 1H),
2.91−2.82 (m, 2H), 2.67 (ddd, J = 12.4, 7.2, 1.2, Hz, 1H), 1.39 (s,
3H), 1.30 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 146.6, 145.8,
137.2, 135.8, 134.7, 134.5, 131.0, 130.9, 129.2, 128.7, 128.6, 118.5,
116.8, 111.3, 91.7, 56.4, 50.2, 41.0, 33.6, 26.2, 25.4 ppm. HRMS-ESI
calcd for C27H30NO4S2
+ [M + H]+: 496.1611; found: 496.1638.
4-Methoxy-N-(2-(2-methylene-4,4-bis(phenylsulfonyl)-
cyclopentyl)propan-2-yl)aniline (4n). Obtained using catalyst A (1.9
mg, 2.5 μmol), enyne 1b (0.12 mL, 1.0 M in dry CH2Cl2, 0.12 mmol),
and 4-methoxyaniline (15 mg, 0.12 mmol) as the nucleophile in
CH2Cl2 (0.8 mL) according to General Procedure I. Preparative TLC
(c-hexane/EtOAc 5:1) yielded 59 mg (90%) of the aminated product
as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 8.10 (dd, J = 8.0, 0.8
Hz, 2H), 7.99 (dd, J = 8.4, 1.2 Hz, 2H), 7.75−7.71 (m, 2H), 7.62 (t, J
= 8.0 Hz, 2H), 7.55 (t, J = 8.0 Hz, 2H), 6.78 (d, J = 9.2 Hz, 2H), 6.72
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(d, J = 9.2 Hz, 2H), 5.08 (s, 1H), 5.04 (s, 1H), 3.80 (s, 3H), 3.56 (qd, J
= 17.2, 2.4 Hz, 1H), 3.16 (dt, J = 8.4, 2.0 Hz, 1H), 2.92−2.83 (m, 2H),
2.69 (ddd, J = 16.8, 8.8, 1.2, Hz, 1H), 1.27 (s, 3H), 1.20 (s, 3H) ppm.
13C NMR (101 MHz, CDCl3) δ 153.9, 146.8, 139.1, 137.2, 135.9,
134.6, 134.5, 131.0, 131.0, 128.7, 128.6, 121.4, 114.4, 111.4, 91.8, 57.0,
55.6, 51.3, 40.9, 33.8, 26.2, 25.3 ppm. HRMS-ESI calcd for
C28H32NO5S2
+ [M + H]+: 526.1716; found: 526.1726.
2-Bromo-N-(2-(2-methylene-4,4-bis(phenylsulfonyl)cyclopentyl)-
propan-2-yl)aniline (4o). Obtained using catalyst A (1.9 mg, 2.5
μmol), enyne 1b (0.12 mL, 1.0 M in dry CH2Cl2, 0.12 mmol), and 2-
bromoaniline (21 mg, 0.124 mmol) as the nucleophile in CH2Cl2 (0.8
mL) according to General Procedure I. Preparative TLC (c-hexane/
EtOAc 5:1) yielded 53 mg (74%) of the aminated product as a
colorless solid. 1H NMR (400 MHz, CDCl3) δ 8.11 (dd, J = 8.8, 1.2
Hz, 2H), 8.01 (dd, J = 8.8, 1.2 Hz, 2H), 7.74−7.70 (m, 2H), 7.63−
7.54 (m, 4H), 7.46 (dd, J = 7.6, 1.2 Hz, 1H), 7.15 (dt, J = 8.4, 2.0 Hz,
1H), 6.90 (dd, J = 8.4, 2.4 Hz, 1H), 6.61 (dt, J = 8.0, 1.2 Hz, 1H), 5.06
(s, 1H), 5.00 (s, 1H), 4.43 (br s, 1H), 3.61 (qd, J = 17.2, 2.4 Hz, 1H),
3.47 (t, J = 7.6 Hz, 1H), 2.84 (d, J = 17.6 Hz, 1H), 2.73 (dd, J = 15.6,
8.4 Hz, 1H), 2.58 (ddd, J = 15.6, 9.2, 1.6 Hz, 1H), 1.49 (s, 3H), 1.34
(s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 146.4, 142.7, 137.0,
135.7, 134.7, 134.6, 132.9, 131.1, 131.0, 128.7, 128.7, 128.2, 118.5,
114.5, 111.9, 111.5, 91.7, 56.7, 49.4, 40.7, 33.7, 26.2, 25.2 ppm.
HRMS-ESI calcd for C27H28BrNO4S2Na
+ [M + Na]+: 596.0535;
found: 596.0566. Mp 191−192 °C.
4-Bromo-N-(2-(2-methylene-4,4-bis(phenylsulfonyl)cyclopentyl)-
propan-2-yl)aniline (4p). Obtained using catalyst A (1.9 mg, 2.5
μmol), enyne 1b (0.12 mL, 1.0 M in dry CH2Cl2, 0.124 mmol), and 4-
bromoaniline (21.4 mg, 0.12 mmol) as the nucleophile in CH2Cl2 (0.8
mL) according to General Procedure I. Preparative TLC (c-hexane/
EtOAc 5:1) yielded 67 mg (93%) of the aminated product as a
colorless foam. 1H NMR (400 MHz, CDCl3) δ 8.07 (dd, J = 8.4, 1.2
Hz, 2H), 7.05 (dd, J = 8.4, 1.2 Hz, 2H), 7.76−7.70 (m, 2H), 7.64−
7.53 (m, 4H), 7.27−7.25 (m, 2H), 6.58−6.55 (m, 2H), 5.03 (s, 1H),
5.00 (s, 1H), 3.70 (br s, 1H), 3.53 (qd, J = 17.2, 2.4 Hz, 1H), 3.32 (dt,
J = 8.4, 2.4 Hz, 1H), 2.87 (d, J = 17.2 Hz, 1H), 2.79 (dd, J = 15.6, 8.8,
Hz 1H), 2.62 (ddd, J = 15.6, 8.8, 1.6 Hz, 1H), 1.48 (s, 3H), 1.33 (s,
3H) ppm. 13C NMR (101 MHz, CDCl3) δ 146.5, 144.9, 137.1, 135.7,
134.7, 134.6, 132.0, 131.9, 131.0, 128.7, 128.6, 118.1, 116.7, 111.3,
91.6, 56.5, 49.9, 41.0, 33.5, 26.1, 25.3 ppm. HRMS-ESI calcd for
C27H27BrNO4S2
− [M − H]−: 572.0570; found: 572.0593. Mp 116−
118 °C.
N-(2-(2-Methylene-4,4-bis(phenylsulfonyl)cyclopentyl)propan-2-
yl)-3,5-bis(trifluoromethyl)aniline (4q). Obtained using catalyst A
(1.9 mg, 2.5 μmol), enyne 1b (0.12 mL, 1.0 M in dry CH2Cl2, 0.12
mmol) and 3,5-bis(trifluoromethyl)aniline (0.25 mL, 0.5 M in CH2Cl2,
0.12 mmol) as the nucleophile in CH2Cl2 (0.6 mL) according to
General Procedure I. Preparative TLC (c-hexane/EtOAc 5:1) yielded
38 mg (48%) of the aminated product as a colorless oil. 1H NMR (400
MHz, CDCl3) δ 8.09 (dd, J = 8.4, 1.2 Hz, 2H), 7.98 (dd, J = 8.4, 1.2
Hz, 2H), 7.77−7.69 (m, 2H), 7.64−7.61 (m, 2H), 7.56−7.52 (m, 2H),
7.21 (br s, 1H), 7.00 (br s, 2H), 5.02 (s, 1H), 4.93 (s, 1H), 4.20 (s,
1H), 3.54 (qd, J = 17.6, 2.4, Hz, 1H), 3.24 (t, J = 9.2 Hz, 1H), 2.97 (d,
J = 17.6 Hz, 1H), 2.83 (dd, J = 16.0, 8.4 Hz, 1H), 2.67 (ddd, J = 16.0,
8.4, 1.6 Hz, 1H), 1.45 (s, 3H), 1.38 (s, 3H) ppm. 13C NMR (101
MHz, CDCl3) δ 146.6, 146.1, 137.0, 135.8, 134.9, 134.7, 132.4 (q, J =
32.0 Hz), 131.0, 130.9, 128.8, 128.7, 123.4 (q, J = 271.0 Hz), 114.4 (q,
J = 4.0 Hz), 111.8, 110.8 (sept, J = 4.0 Hz), 92.3, 56.7, 50.2, 41.0, 33.3,
25.9, 25.2 ppm. HRMS-ESI calcd for C29H26F6NO4S2
− [M − H]−:
630.1213; found: 630.1215.
N-(2-(2-Methylene-4,4-bis(phenylsulfonyl)cyclopentyl)propan-2-
yl)naphthalen-1-amine (4r). Obtained using catalyst A (1.9 mg, 2.5
μmol), enyne 1b (0.12 mL, 1.0 M in dry CH2Cl2, 0.12 mmol), and
naphtalen-1-amine (18 mg, 0.12 mmol) as the nucleophile in CH2Cl2
(0.8 mL) according to General Procedure I. Preparative TLC (c-
hexane/EtOAc 5:1) yielded 50 mg (74%) of the aminated product as a
colorless solid. 1H NMR (400 MHz, CDCl3) δ 8.07 (dd, J = 8.4, 1.2
Hz, 2H), 7.98 (dd, J = 8.4, 1.2 Hz, 2H), 7.84−7.80 (m, 2H), 7.71−
7.66 (m, 2H), 7.56−7.47 (m, 6H), 7.36−7.31 (m, 2H), 6.87 (dd, J =
7.2, 1.6 Hz, 1H), 5.04 (br s, 1H), 4.98 (br s, 1H), 4.39 (br s, 1H),
3.65−3.60 (m, 2H), 2.91−2.85 (m, 2H), 2.64 (ddd, J = 15.6, 8.8, 1.6
Hz, 1H), 1.53 (s, 3H), 1.45 (s, 3H) ppm. 13C NMR (101 MHz,
CDCl3) δ 146.7, 140.9, 137.2, 135.8, 134.7, 134.6, 134.5, 131.0, 130.9,
128.7, 128.6, 125.6, 125.0, 124.9, 119.9, 118.3, 111.4, 109.1, 91.7, 56.5,
49.7, 40.9, 33.7, 26.1, 25.4 ppm. HRMS-ESI calcd for
C31H31NO4S2Na
+ [M + Na]+: 568.1587; found: 568.1591. Mp 89−
92 °C.
N-(2-(2-Methylene-4,4-bis(phenylsulfonyl)cyclopentyl)propan-2-
yl)quinolin-8-amine (4s). Obtained using catalyst A (1.9 mg, 2.5
μmol), enyne 1b (0.12 mL, 1.0 M in dry CH2Cl2, 0.12 mmol), and
quinolin-8-amine (20 mg, 0.12 mmol) as the nucleophile in CH2Cl2
(0.8 mL) according to General Procedure I. Preparative TLC (c-
hexane/EtOAc 5:1) yielded slightly contaminated product. Recrystal-
lization from c-hexane/EtOAc yielded 49 mg (72%) of the pure
aminated product as a pale yellow solid. 1H NMR (400 MHz, CDCl3)
δ 8.77 (dd, J = 4.0, 1.6 Hz, 1H), 8.07 (dd, J = 8.4, 2.0 Hz, 1H), 8.04
(dd, J = 8.8, 1.2 Hz, 2H), 7.98 (dd, J = 8.8, 1.2 Hz, 2H), 7.71−7.41 (m,
6H), 7.38 (dd, J = 8.4, 4.4 Hz, 1H), 7.34 (t, J = 8.4 Hz, 1H), 7.08 (dd,
J = 8.0, 0.8 Hz, 1H), 6.89 (dd, J = 8.4, 0.8 Hz, 1H), 6.66 (s, 1H), 5.04
(s, 1H), 4.97 (s, 1H), 3.69−3.59 (m, 2H), 2.86−2.77 (m, 2H), 2.53
(ddd, J = 15.6, 8.8, 1.6 Hz), 1.57 (s, 3H), 1.45 (s, 3H) ppm. 13C NMR
(101 MHz, CDCl3) δ 146.8, 146.7, 142.0, 138.6, 137.0, 136.2, 135.6,
134.7, 134.5, 131.0, 130.9, 130.8, 129.6, 129.1, 128.9, 128.7, 128.6,
128.5, 127.5, 121.4, 114.3, 111.2, 107.2, 91.6, 55.9, 48.4, 40.8, 33.6,
25.8, 25.0 ppm. HRMS-ESI calcd for C30H31N2O4S2
+ [M + H]+:
547.1720; found: 547.1720. Mp 82−85 °C.
N-Methyl-N-(2-(2-methylene-4,4-bis(phenylsulfonyl)cyclopentyl)-
propan-2-yl)aniline (4t). Obtained using catalyst A (1.9 mg, 2.5
μmol), enyne 1b (0.12 mL, 1.0 M in dry CH2Cl2, 0.12 mmol), and N-
methylaniline (0.25 mL, 0.5 M in CH2Cl2, 0.12 mmol) as the
nucleophile in CH2Cl2 (0.6 mL) according to General Procedure I.
Preparative TLC (c-hexane/EtOAc 5:1) yielded 53 mg (83%) of the
aminated product as a colorless solid. 1H NMR (400 MHz, CDCl3) δ
8.15 (dd, J = 7.6, 1.2 Hz, 2H), 8.07 (dd, J = 7.6, 1.2 Hz, 2H), 7.77−
7.71 (m, 2H), 7.66−7.58 (m, 4H), 7.33−7.30 (m, 2H), 7.17−7.14 (m,
3H), 5.12 (s, 1H), 5.05 (s, 1H), 3.56 (qd, J = 17.2, 2.0 Hz, 1H), 3.22
(t, J = 7.6 Hz, 1H), 3.08 (dd, J = 15.6, 8.0 Hz, 1H), 2.80 (d, J = 17.2
Hz, 1H), 2.72−2.69 (m, 1H+3H), 1.18 (s, 3H), 0.85 (s, 3H) ppm. 13C
NMR (101 MHz, CDCl3) δ 150.5, 147.3, 137.3, 135.9, 134.6, 134.5,
131.1, 131.0, 128.7, 128.6, 128.2, 128.1, 124.4, 111.3, 91.9, 60.4, 50.4,
40.9, 36.4, 34.0, 21.8, 20.7 ppm. HRMS-ESI calcd for
C28H31NO4S2Na
+ [M + Na]+: 532.1587; found: 532.1586. Mp 171−
172 °C.
Dimethyl 3-Methylene-4-(2-(phenylamino)propan-2-yl)cyclo-
pentane-1,1-dicarboxylate (4u). Obtained using catalyst A (2.2 mg,
2.8 μmol), enyne 1c (35 mg, 0.15 mmol), and aniline (15 μL, 0.16
mol) as the nucleophile in CH2Cl2 (1.0 mL) according to General
Procedure I. Purification by column chromatography (c-hexane/
EtOAc 13:1) yielded 40 mg (83%) of the aminated product as a
colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.17−7.11 (m, 2H),
6.76−6.69 (m, 3H), 5.07 (br s, 1H), 4.97 (br s, 1H), 3.72 (s, 3H), 3.70
(s, 3H), 3.61 (br s, 1H), 3.23−3.19 (m, 1H), 2.94−2.84 (m, 2H), 2.63
(ddd, J = 13.5, 8.4, 1.2 Hz, 1H), 2.05 (dd, J = 13.5, 9.4 Hz, 1H), 1.31
(s, 3H), 1.29 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 172.0,
171.9, 148.5, 146.3, 129.2, 118.3, 117.2, 111.1, 58.6, 56.3, 52.8, 49.1,
44.0, 36.4, 27.0, 25.9, 25.8 ppm. HRMS-ESI calcd for C19H26NO4
+ [M
+ H]+: 332.1856; found: 332.1857.
Dimethyl 3-(2-((4-Methoxyphenyl)amino)propan-2-yl)-4-
methylenecyclopentane-1,1-dicarboxylate (4v). Obtained using
catalyst A (2.3 mg, 3.0 μmol), enyne 1c (36 mg, 0.15 mmol), and
p-anisidine (20 mg, 0.16 mmol) as the nucleophile in CH2Cl2 (1 mL)
according to General Procedure I. Purification by column chromatog-
raphy (c-hexane/EtOAc 8:1) yielded 44 mg (81%) of the aminated
product as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.75 (br s,
4H), 5.10 (br s, 1H), 5.04 (br s, 1H), 3.75 (s, 3H), 3.73 (s, 3H), 3.71
(s, 3H), 3.16 (br s, 1H), 3.03−2.83 (m, 3H), 2.64 (ddd, J = 13.4, 8.5,
1.7 Hz, 1H), 2.12 (dd, J = 13.4, 9.3 Hz, 1H), 1.21 (s, 3H), 1.19 (s, 3H)
ppm. 13C NMR (101 MHz, CDCl3) δ 172.1, 172.0, 154.0, 148.7,
139.4, 122.0, 114.4, 111.3, 58.7, 56.9, 55.6, 52.8, 50.4, 44.0, 36.4, 27.0,
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25.9, 25.7 ppm. HRMS-ESI calcd for C20H27NO5Na
+ [M + Na]+:
384.1781; found: 384.1801.
Dimethyl 3-(2-((2-Bromophenyl)amino)propan-2-yl)-4-
methylenecyclopentane-1,1-dicarboxylate (4w). Obtained using
catalyst A (34 mg, 0.04 mmol), enyne 1c (525 mg, 2.20 mmol),
and 2-bromoaniline (417 mg, 2.42 mmol) as the nucleophile in
CH2Cl2 (14 mL) according to General Procedure I. Purification by
column chromatography (pentane/Et2O 9:1) yielded 649 mg (72%)
of the aminated product as a colorless oil. 1H NMR (500 MHz,
CDCl3) δ 7.43 (dd, J = 7.9, 1.5 Hz, 1H), 7.12 (ddd, J = 8.6, 7.4, 1.6 Hz,
1H), 6.95 (dd, J = 8.3, 1.5 Hz, 1H), 6.55 (ddd, J = 7.9, 7.3, 1.5 Hz,
1H), 5.08 (t, J = 2.3 Hz, 1H), 4.91 (ddt, J = 2.9, 1.8, 0.9 Hz, 1H), 4.43
(s, 1H), 3.73 (s, 3H), 3.71 (s, 3H), 3.27 (ddd, J = 9.4, 8.5, 2.0 Hz, 1H),
2.95 (dq, J = 15.3, 2.6 Hz, 1H), 2.88 (ddt, J = 15.2, 1.9, 1.1 Hz, 1H),
2.62 (ddd, J = 13.6, 8.6, 1.9 Hz, 1H), 2.02 (dd, J = 13.6, 9.5 Hz, 1H),
1.38 (s, 3H), 1.36 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ
172.0, 171.9, 147.9, 143.3, 133.0, 128.2, 118.1, 114.8, 112.1, 111.5,
58.7, 56.7, 52.9, 48.8, 44.1, 36.4, 25.7, 25.6 ppm. HRMS-ESI calcd for
C19H24BrNO4Na
+ [M + Na]+: 432.0781; found: 432.0785.
Dimethyl 3-(2-((4-Bromophenyl)amino)propan-2-yl)-4-
methylenecyclopentane-1,1-dicarboxylate (4x). Obtained using
catalyst A (2.3 mg, 3.0 μmol), enyne 1c (35 mg, 0.15 mmol), and
4-bromoaniline (28 mg, 0.16 mmol) as the nucleophile in CH2Cl2 (1.0
mL) according to General Procedure I. Purification by column
chromatography (c-hexane/EtOAc 9:1) yielded 37 mg (62%) of the
aminated product as a colorless solid. 1H NMR (400 MHz, CDCl3) δ
7.27−7.24 (m, 2H), 6.65−6.58 (m, 2H), 5.09 (br s, 1H), 4.95 (br s,
1H), 3.75 (s, 3H), 3.73 (s, 3H), 3.69 (br s, 1H), 3.23−3.17 (m, 1H),
2.90 (br s, 2H), 2.62 (dd, J = 13.5, 8.4 Hz, 1H), 2.03 (dd, J = 13.5, 9.3
Hz, 1H), 1.32 (s, 3H), 1.29 (s, 3H) ppm. 13C NMR (101 MHz,
CDCl3) δ 172.0, 171.8, 148.3, 145.4, 132.0, 118.4, 111.2, 110.1, 58.6,
56.4, 52.9, 48.9, 44.0, 36.4, 25.8 ppm. HRMS-ESI calcd for
C19H25BrNO4
+ [M + H]+: 410.0961; found: 410.0947. Mp 116−118
°C.
Dimethyl 3-(2-((2-Iodophenyl)amino)propan-2-yl)-4-methylene-
cyclopentane-1,1-dicarboxylate (4y). Obtained using catalyst A
(34.2 mg, 0.04 mmol), enyne 1c (500 mg, 2.1 mmol), and 2-
iodoaniline (492 mg, 2.25 mmol) as the nucleophile in CH2Cl2 (6.0
mL) according to General Procedure I. Purification by column
chromatography (pentane/Et2O 10:1 to 4:1) yielded 553 mg (58%) of
the aminated product as a colorless oil. 1H NMR (500 MHz, CDCl3)
δ 7.68 (dd, J = 7.9, 1.6 Hz, 1H), 7.16 (ddd, J = 8.5, 7.2, 1.6 Hz, 1H),
6.91 (dd, J = 8.4, 1.5 Hz, 1H), 6.42 (ddd, J = 8.0, 7.3, 1.4 Hz, 1H), 5.10
(br s, 1H), 4.92 (br s, 1H), 4.25 (s, 1H), 3.74 (s, 3H), 3.72 (s, 3H),
3.31−3.25 (m, 1H), 2.97 (dq, J = 15.2, 2.6 Hz, 1H), 2.90 (d, J = 15.3
Hz, 1H), 2.63 (ddd, J = 13.7, 8.6, 2.0 Hz, 1H), 2.04 (dd, J = 13.6, 9.5
Hz, 1H), 1.40 (s, 3H), 1.36 (s, 3H) ppm. 13C NMR (126 MHz,
CDCl3) δ 171.7, 171.7, 147.7, 145.4, 139.6, 129.0, 118.8, 113.8, 111.4,
88.7, 58.5, 56.9, 52.7, 48.6, 43.9, 36.2, 25.6, 25.3 ppm. HRMS-ESI
calcd for C19H24INO4Na
+ [M + Na]+: 480.0642, found 480.0638.
Dimethyl 3-(2-((4-Acetylphenyl)amino)propan-2-yl)-4-
methylenecyclopentane-1,1-dicarboxylate (4z). Obtained using
catalyst A (2.3 mg, 2.9 μmol), enyne 1c (0.15 mL, 1.0 M in dry
CH2Cl2, 0.15 mmol), and 1-(4-aminophenyl)ethanone (20 mg, 0.15
mmol) as the nucleophile in CH2Cl2 (0.8 mL) according to General
Procedure I. Preparative TLC (c-hexane/EtOAc 5:1) yielded 40 mg
(74%) of the aminated product as a colorless oil. 1H NMR (400 MHz,
CDCl3) δ 7.87−7.85 (m, 2H), 6.69−6.66 (m, 2H), 5.09 (s, 1H), 4.91
(s, 1H), 4.31 (s, 1H), 3.75 (s, 3H), 3.73 (s, 3H), 3.37 (t, J = 9.2 Hz,
1H), 2.92 (s, 2H), 2.65 (dd, J = 13.6, 8.8 Hz, 1H), 2.51 (s, 3H), 2.00
(dd, J = 13.6, 8.8 Hz, 1H), 1.41 (s, 3H), 1.39 (s, 3H) ppm. 13C NMR
(101 MHz, CDCl3) δ 196.2, 171.8, 171.6, 150.5, 147.9, 130.7, 126.6,
113.7, 111.0, 58.4, 56.3, 52.8, 48.0, 43.9, 36.2, 26.0, 25.5, 25.4 ppm.
HRMS-ESI calcd for C21H26NO5
− [M − H]−: 372.1816; found:
372.1817.
Dimethyl 3-(2-((3,5-Bis(trifluoromethyl)phenyl)amino)propan-2-
yl)-4-methylenecyclopentane-1,1-dicarboxylate (4aa). Obtained
using catalyst A (2.4 mg, 3 μmol), enyne 1c (35 mg, 0.14 mmol),
and 3,5-bis(trifluoromethyl)aniline (25 μL, 0.16 mmol) as the
nucleophile in CH2Cl2 (1.0 mL) according to General Procedure I.
Preparative TLC (c-hexane/EtOAc 15:1) yielded 28 mg (42%) of the
aminated product as a colorless oil. 1H NMR (400 MHz, CDCl3) δ
7.16 (s, 1H), 7.04 (s, 2H), 5.15−5.12 (m, 1H), 4.99−4.96 (m, 1H),
4.17 (br s, 1H), 3.74 (s, 3H), 3.72 (s, 3H), 3.18 (dddd, J = 10.3, 8.6,
4.0, 2.0 Hz, 1H), 2.94 (dq, J = 15.3, 1.2 Hz, 1H), 2.88 (dq, J = 15.4, 2.6
Hz, 1H), 2.62 (ddd, J = 13.6, 8.5, 1.8 Hz, 1H), 2.04 (dd, J = 13.6, 9.6
Hz, 1H), 1.40 (s, 3H), 1.36 (s, 3H) ppm. 13C NMR (101 MHz,
CDCl3) δ 171.7, 171.5, 147.8, 147.0, 132.3 (q, J = 32.7 Hz), 123.5 (q, J
= 272.7 Hz), 114.6 (app. d, J = 4.2 Hz), 111.4, 110.5 (quintet, J = 3.7
Hz), 58.3, 56.5, 52.8, 52.8, 49.0, 43.8, 36.1, 25.6, 25.3 ppm. 19F NMR
(376 MHz, CDCl3) δ − 63.3 ppm. HRMS-ESI calcd for
C21H23F6NO4Na
+ [M + Na]+: 490.1423; found: 490.1430.
Dimethyl 3-Methylene-4-(2-(naphthalen-1-ylamino)propan-2-
yl)cyclopentane-1,1-dicarboxylate (4ab). Obtained using catalyst A
(2.3 mg, 2.9 μmol), enyne 1c (0.15 mL, 1.0 M in dry CH2Cl2, 0.15
mmol), and naphtalen-1-amine (21 mg, 0.15 mmol) as the nucleophile
in CH2Cl2 (0.8 mL) according to General Procedure I. Preparative
TLC (c-hexane/EtOAc 5:1) yielded 44 mg (78%) of the aminated
product as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.82−7.78
(m, 2H), 7.48−7.43 (m, 2H), 7.34 (t, J = 8.0 Hz, 1H), 7.26 (d, J = 8.0
Hz, 1H), 6.97 (d, J = 7.6 Hz, 1H), 5.10 (br s, 1H), 4.94 (br s, 1H),
4.41 (s, 1H), 3.75 (s, 3H), 3.74 (s, 3H), 3.48 (dt, J = 9.2, 1.6 Hz, 1H),
3.03−2.92 (m, 2H), 2.72 (ddd, J = 13.6, 8.8, 1.6 Hz, 1H), 2.14 (dd, J =
13.6, 8.8 Hz, 1H), 1.47 (s, 3H), 1.46 (s, 3H) ppm. 13C NMR (101
MHz, CDCl3) δ 171.9, 171.8, 148.3, 140.9, 134.7, 128.9, 126.2, 125.5,
125.1, 124.8, 120.1, 117.9, 111.2, 109.3, 58.6, 55.5, 52.8, 48.7, 44.0,
36.4, 25.5 ppm. HRMS-ESI calcd for C23H28NO4
+ [M + H]+:
382.2013; found: 382.2022.
Dimethyl 3-Methylene-4-(2-(quinolin-8-ylamino)propan-2-yl)-
cyclopentane-1,1-dicarboxylate (4ac). Obtained using catalyst A
(2.3 mg, 2.94 μmol), enyne 1c (0.15 mL, 1.0 M in dry CH2Cl2, 0.15
mmol), and quinolin-8-amine (21 mg, 0.15 mmol) as the nucleophile
in CH2Cl2 (0.8 mL) according to General Procedure I. Preparative
TLC (c-hexane/EtOAc 5:1) yielded 45 mg (81%) of the aminated
product as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ 8.71 (dd, J
= 4.0, 1.6 Hz, 1H), 8.05 (dd, J = 8.4, 1.6 Hz, 1H), 7.38−7.33 (m, 2H),
7.05 (d, J = 8.0 Hz, 1H), 6.98 (d, J = 8.4 Hz, 1H), 6.65 (s, 1H), 5.05
(s, 1H), 4.89 (s, 1H), 3.73 (s, 3H), 3.72 (s, 3H), 3.59−3.55 (m, 1H),
3.01 (qd, J = 15.2, 2.0 Hz, 1H), 2.92 (d, J = 15.2 Hz, 1H), 2.66 (ddd, J
= 13.6, 8.4, 1.6 Hz, 1H), 2.07 (dd, J = 13.6, 8.4 Hz, 1H), 1.57 (s, 3H),
1.53 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 171.9, 171.8, 148.1,
146.6, 142.3, 138.7, 136.1, 128.9, 127.5, 121.2, 113.5, 110.9, 106.9,
58.6, 55.6, 52.7, 47.5, 44.0, 36.3, 30.9, 25.2, 25.0 ppm. HRMS-ESI
calcd for C22H27N2O4
+ [M + H]+: 383.1965; found: 383.1975.
Dimethyl 3-(2-(Methyl(phenyl)amino)propan-2-yl)-4-methylene-
cyclopentane-1,1-dicarboxylate (4ad). Obtained using catalyst A
(3.2 mg, 4.2 μmol), enyne 1c (0.21 mL, 1.0 M in dry CH2Cl2, 0.21
mmol), and N-methylaniline (0.46 mL, 0.5 M in CH2Cl2, 0.23 mmol)
as the nucleophile in CH2Cl2 (0.5 mL) according to General
Procedure I. Preparative TLC (c-hexane/EtOAc 5:1) yielded 61 mg
(85%) of the aminated product as a colorless oil. 1H NMR (400 MHz,
CDCl3) δ 7.25−7.23 (m, 2H), 7.19−7.14 (m, 2H), 7.13−7.08 (m,
1H), 5.14 (br s, 1H), 5.08 (br s, 1H), 3.75 (s, 3H), 3.73 (s, 3H), 3.10−
3.05 (m, 1H), 2.97−2.84 (m, 2H), 2.73 (s, 3H), 2.63 (ddd, J = 13.8,
8.6, 1.7 Hz, 1H), 2.21 (dd, J = 13.8, 9.3 Hz, 1H), 1.08 (s, 3H), 0.89 (s,
3H) ppm. 13C NMR (101 MHz, CDCl3) δ 171.9, 171.8, 150.9, 148.9,
128.3, 128.0, 124.1, 110.8, 60.0, 58.4, 52.7, 48.8, 44.0, 36.6, 36.3, 21.5,
20.8 ppm. HRMS-ESI calcd for C20H28NO4
+ [M + H]+: 346.2013;
found: 346.2015.
Dimethyl 3-(2-(Allyl(phenyl)amino)propan-2-yl)-4-methylene-
cyclopentane-1,1-dicarboxylate (4ae). Obtained using catalyst A
(11 mg, 15.0 μmol), enyne 1c (0.29 mL, 1.0 M in dry CH2Cl2, 0.29
mmol), and N-allylaniline (70 mg, 0.29 mmol) as the nucleophile in
CH2Cl2 (1.5 mL) according to General Procedure I. Flash column
chromatography (c-hexane/EtOAc 5:1) yielded 54 mg (49%) of the
aminated product as a colorless solid. 1H NMR (400 MHz, CDCl3) δ
7.25 (t, J = 8.0 Hz, 2H), 7.16 (d, J = 8.0 Hz, 2H), 7.11 (t, J = 8.0 Hz,
1H), 5.66−5.58 (m, 1H), 5.16 (s, 1H), 5.11 (s, 1H), 4.98 (dd, J = 17.5,
1.5 Hz, 1H), 4.85 (dd, J = 17.5, 1.5 Hz, 1H), 3.79 (s, 3H), 3.77−3.76
(m, 3H + 2H), 3.13−3.07 (m, 1H), 2.96−2.87 (m, 2H), 2.66 (ddd, J =
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14.0, 8.5, 1.5 Hz, 1H), 2.30 (dd, J = 13.5, 9.0 Hz, 1H), 1.11 (s, 3H),
0.88 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 172.2, 172.1, 149.1,
147.9, 137.2, 130.0, 127.9, 124.8, 115.7, 110.9, 60.4, 58.5, 52.7, 52.6,
50.6, 49.2, 44.1, 36.7, 22.2, 21.9 ppm. HRMS-ESI calcd for
C22H30NO4
+ [M + H]+: 372.2169; found: 372.2156. Mp 75−77 °C.
Dimethyl 3-(2-(Indolin-1-yl)propan-2-yl)-4-methylenecyclo-
pentane-1,1-dicarboxylate (4af). Obtained using catalyst A (11 mg,
15.0 μmol), enyne 1c (0.29 mL, 1.0 M in dry CH2Cl2, 0.29 mmol),
and indoline (0.29 mL, 1.0 M in dry CH2Cl2, 0.29 mmol) as the
nucleophile in CH2Cl2 (1.5 mL) according to General Procedure I.
Flash column chromatography (c-hexane/EtOAc 5:1) yielded 92 mg
(87%) of the aminated product as a colorless oil. 1H NMR (400 MHz,
CDCl3) δ 7.06 (dd, J = 7.5, 0.5 Hz, 1H), 7.01 (t, J = 8.0 Hz, 1H), 6.80
(d, J = 8.0 Hz, 1H), 6.63 (dd, J = 7.5, 0.5 Hz, 1H), 5.07 (br s, 2H),
3.76 (s, 3H), 3.75 (s, 3H), 3.60 (t, J = 10.0 Hz, 1H), 3.52−3.41 (m,
2H), 2.93 (br s, 2H), 2.88 (t, J = 8.5 Hz, 2H), 2.63 (ddd, J = 13.5, 8.5,
1.5 Hz, 1H), 2.10 (dd, J = 13.5, 9.0 Hz, 1H), 1.37 (s, 3H), 1.27 (s, 3H)
ppm. 13C NMR (101 MHz, CDCl3) δ 172.0, 171.9, 149.8, 148.5,
131.6, 126.9, 124.4, 116.6, 110.6, 109.8, 58.7, 58.3, 52.8, 52.7, 49.6,
48.5, 44.0, 36.2, 28.1, 21.4, 21.0 ppm. HRMS-ESI calcd for
C21H28NO4
+ [M + H]+: 358.2013; found: 358.2025.
Dimethyl 3-(2-(3,4-Dihydroquinolin-1(2H)-yl)propan-2-yl)-4-
methylenecyclopentane-1,1-dicarboxylate (4ag). Obtained using
catalyst A (11 mg, 15.0 μmol), enyne 1c (0.29 mL, 1.0 M in dry
CH2Cl2, 0.29 mmol), and 1,2,3,4-tetrahydroquinoline (0.29 mL, 1.0 M
in dry CH2Cl2, 0.29 mmol) as the nucleophile in CH2Cl2 (1.5 mL)
according to General Procedure I. Washing with 10% aqueous solution
of NaOH to remove excess 1,2,3,4-tetrahydroquinoline, flash column
chromatography (c-hexane/EtOAc 5:1), and subsequent preparative
TLC (CH2Cl2/c-hexane 1:2) yielded 56 mg (51%) of the aminated
product as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.06−7.04
(m, 2H), 7.01 (d, J = 7.5 Hz, 1H), 6.74 (dt, J = 6.5, 2.5 Hz, 1H), 5.06
(s, 1H), 4.98 (s, 1H), 3.75 (s, 3H), 3.72 (s, 3H), 3.62 (dt, J = 10.0, 2.0
Hz, 1H), 3.33−3.28 (m, 1H), 3.23−3.18 (m, 1H), 2.97−2.89 (m, 2H),
2.65 (t, J = 6.5 Hz, 2H), 2.55 (ddd, J = 13.6, 8.0, 1.5 Hz, 1H), 2.06 (dd,
J = 13.5, 9.5 Hz, 1H), 1.89 (quin, J = 6.5 Hz, 2H), 1.43 (s, 3H), 1.32
(s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 172.1, 171.9, 148.9,
145.9, 131.1, 128.4, 125.4, 119.8, 118.3, 110.5, 60.8, 58.4, 52.8, 52.7,
48.8, 44.3, 44.1, 36.6, 28.0, 25.3, 24.3, 23.6 ppm. HRMS-ESI calcd for
C22H30NO4
+ [M + H]+: 372.2169; found: 372.2162.
4-Bromo-N-((8,8-dimethyl-3-methylene-7,9-dioxaspiro[4,5]-
decan-2-yl)(phenyl)methyl)aniline (4ah). Obtained using catalyst A
(4.6 mg, 0.006 mmol), enyne 1d (81 mg, 0.30 mmol), and 4-
bromoaniline (57 mg, 0.33 mmol) as the nucleophile in CH2Cl2 (0.9
mL) according to General Procedure I (stirred vigorously at rt for 5
h). Purification by column chromatography (pentane/Et2O 95:5 to
9:1) yielded 125 mg of colorless gum (94%, contains ca. 3−5%
impurities) that was further crystallized from 0.4 mL of diethyl ether
layered with 1.2 mL of pentane (sonication initiated the
crystallization) to yield 110 mg of colorless crystals (84%). 1H
NMR (500 MHz, CDCl3) δ 7.32 (app. d, J = 4.3 Hz, 4H), 7.25 (ddd, J
= 8.7, 4.9, 3.9 Hz, 1H), 7.17−7.12 (m, 2H), 6.40−6.35 (m, 2H), 5.07
(br s, 1H), 4.77 (q, J = 2.1 Hz, 1H), 4.43 (d, J = 5.2 Hz, 1H), 4.02 (br
s, 1H), 3.72 (d, J = 11.2 Hz, 1H), 3.66 (d, J = 11.4 Hz, 1H), 3.55−3.48
(m, 2H), 2.99 (dddt, J = 10.6, 7.9, 5.2, 2.2 Hz, 1H), 2.53 (dq, J = 16.5,
1.6 Hz, 1H), 2.18 (dq, J = 16.4, 2.4 Hz, 1H), 1.67 (dd, J = 13.6, 8.2 Hz,
1H), 1.50 (dd, J = 13.6, 10.3 Hz, 1H), 1.40 (s, 3H), 1.38 (s, 3H) ppm.
13C NMR (126 MHz, CDCl3) δ 149.0, 146.7, 141.7, 131.7, 128.5,
127.2, 126.8, 115.5, 109.5, 109.5, 97.9, 69.4, 67.5, 59.9, 48.8, 41.7, 39.4,
34.0, 24.7, 22.8 ppm. HRMS-ESI calcd for C24H28BrNO2Na
+ [M +
Na]+: 464.1196; found: 464.1197. Mp 110−112 °C.
N-((4,4-Bis(methoxymethyl)-2-methylenecyclopropentyl(phenyl)-
methyl)-4-bromoaniline (4ai). Obtained using catalyst A (3.9 mg,
0.005 mmol), enyne 1f (64.6 mg, 0.25 mmol), and 4-bromoaniline (47
mg, 0.275 mmol) as the nucleophile in CH2Cl2 (1.0 mL) according to
General Procedure I (stirred vigorously at r.t. for 5 h). Purification by
column chromatography (pentane/Et2O 95:5 to 85:15) yielded 80 mg
(74%) of the aminated product as a colorless oil. 1H NMR (500 MHz,
CDCl3) δ 7.35−7.28 (m, 4H), 7.25−7.20 (m, 1H), 7.15−7.11 (m,
2H), 6.37−6.32 (m, 2H), 4.98 (q, J = 2.1 Hz, 1H), 4.75 (q, J = 2.1 Hz,
1H), 4.50−4.46 (m, 2H), 3.41 (s, 3H), 3.32 (s, 2H), 3.27 (s, 3H), 3.12
(s, 2H), 3.02 (t, J = 8.2 Hz, 1H), 2.40 (dq, J = 16.3, 2.3 Hz, 1H), 2.31
(d, J = 16.2 Hz, 1H), 1.75 (dd, J = 13.9, 9.1 Hz, 1H), 1.51 (dd, J =
13.9, 9.3 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 151.2, 147.0,
142.3, 131.6, 128.5, 126.9, 126.7, 115.1, 108.7, 107.7, 77.7, 76.2, 60.4,
59.3, 59.3, 49.7, 45.4, 40.5, 32.2 ppm. HRMS-ESI calcd for
C23H28BrNO2Na
+ [M + Na]+: 452.1196; found: 452.1197.
N-((4,4-Bis(((4-methoxybenzyl)oxy)methyl)-2-methylenecyclo-
pentyl)(phenyl)methyl)-4-bromoaniline (4aj). Obtained using cata-
lyst A (2.0 mg, 0.0026 mmol), enyne 1e (61 mg, 0.13 mmol), and 4-
bromoaniline (57 mg, 0.143 mmol) as the nucleophile in CH2Cl2 (0.6
mL) according to General Procedure I (stirred vigorously at rt for 5
h). Purification by column chromatography (pentane/Et2O 95:5 to
85:15) yielded 61 mg (73%) of the aminated product as a colorless oil.
1H NMR (500 MHz, CDCl3) δ 7.34−7.21 (m, 7H), 7.18−7.13 (m,
2H), 7.10−7.06 (m, 2H), 6.92−6.88 (m, 2H), 6.87−6.83 (m, 2H),
6.20−6.15 (m, 2H), 4.97 (q, J = 2.1 Hz, 1H), 4.74 (q, J = 2.1 Hz, 1H),
4.49 (s, 2H), 4.47 (t, J 3.0 Hz, 1H), 4.37 (s, 2H), 4.34 (br s, 1H), 3.83
(s, 3H), 3.82 (s, 3H), 3.46−3.39 (m, 2H), 3.23−3.17 (m, 2H), 2.99
(dddt, J = 9.3, 6.9, 4.5, 2.2 Hz, 1H), 2.46 (dq, J = 16.4, 2.3 Hz, 1H),
2.35 (d, J = 16.2 Hz, 1H), 1.78 (dd, J = 14.0, 9.2 Hz, 1H), 1.52 (dd, J =
13.9, 9.3 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 159.2, 159.0,
151.5, 146.9, 142.3, 131.5, 130.6, 129.3, 128.9, 128.4, 126.9, 126.6,
115.1, 113.8, 113.7, 108.7, 107.5, 74.9, 73.3, 73.1, 72.8, 60.3, 55.3, 55.2,
49.7, 45.5, 40.6, 32.1 ppm. HRMS-ESI calcd for C37H40BrNO4Na
+ [M
+ Na]+: 664.2033; found: 664.2030.
Dimethyl 9b-Methyl-4-phenyl-1,3,3a,9b-tetrahydro-2H-cyclo-
penta[c]quinoline-2,2-dicarboxylate (5e). A solution of compound
4e (40 mg, 0.08 mmol) in degassed DMF (0.5 mL) was treated with
Pd(OAc)2 (1.8 mg, 8 μmol), PPh3 (4.2 mg, 16 μmol), and K2CO3 (22
mg, 0.16 mmol) under a N2 atmosphere, and the solution was heated
at 110 °C for 7 h. Purification by flash column chromatography
(pentane/Et2O 9:1) provided product 5e (20 mg, 67%) as a colorless
oil. 1H NMR (500 MHz, CDCl3) δ 8.12−8.07 (m, 2H), 7.54−7.45
(m, 4H), 7.38 (dd, J = 7.5, 1.6 Hz, 1H), 7.28 (td, J = 7.5, 1.6 Hz, 1H),
7.23 (td, J = 7.4, 1.5 Hz, 1H), 3.79 (s, 3H), 3.50 (s, 3H), 3.45 (d, J =
14.2 Hz, 1H), 3.31 (dd, J = 12.4, 7.8 Hz, 1H), 2.66 (dd, J = 13.8, 7.8
Hz, 1H), 2.54 (d, J = 14.2 Hz, 1H), 2.17 (dd, J = 13.8, 12.4 Hz, 1H),
1.20 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ 173.4, 171.4, 165.8,
142.4, 138.7, 131.7, 130.8, 128.8, 128.6, 127.9, 127.7, 127.0, 125.7,
58.5, 53.2, 52.9, 46.9, 46.5, 44.5, 38.8, 28.7 ppm. HRMS-ESI calcd for
C23H24NO4
+ [M + H]+: 378.1700; found: 378.1697.
Dimethyl 8-Bromo-9b-methyl-4-phenyl-1,3,3a,9b-tetrahydro-2H-
cyclopenta[c]quinoline-2,2-dicarboxylate (5f). A solution of com-
pound 4f (60 mg, 0.11 mmol) in degassed DMF (0.7 mL) was treated
with Pd(OAc)2 (2.3 mg, 10 μmol), PPh3 (5.4 mg, 21 μmol), and
K2CO3 (28 mg, 0.21 mmol) under a N2 atmosphere, and the solution
was heated at 110 °C for 4 h. Purification by flash column
chromatography (pentane/Et2O 9:1) provided product 5f (34 mg,
73%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 8.15−8.04 (m,
2H), 7.52−7.45 (m, 4H), 7.42−7.35 (m, 2H), 3.78 (s, 3H), 3.58 (s,
3H), 3.33 (d, J = 14.3 Hz, 1H), 3.28 (dd, J = 12.2, 8.1 Hz, 1H), 2.63
(dd, J = 13.9, 8.1 Hz, 1H), 2.58 (d, J = 14.3 Hz, 1H), 2.21 (dd, J =
13.9, 12.2 Hz, 1H), 1.20 (s, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ
173.1, 171.2, 166.4, 141.6, 138.3, 133.9, 131.1, 130.9, 130.2, 128.8,
128.8, 127.0, 120.9, 58.5, 53.3, 53.1, 46.8, 46.1, 44.7, 38.9, 28.4 ppm.
HRMS-ESI calcd for C23H23BrNO4
+ [M + H]+: 456.0805; found:
456.0798.
Dimethyl 7-Chloro-9b-methyl-4-phenyl-1,3,3a,9b-tetrahydro-2H-
cyclopenta[c]quinoline-2,2-dicarboxylate (5g). A solution of com-
pound 4g (60 mg, 0.11 mmol) in degassed DMF (0.75 mL) was
treated with Pd(OAc)2 (2.5 mg, 11 μmol), PPh3 (5.8 mg, 22 μmol),
and K2CO3 (31 mg, 0.22 mmol) under a N2 atmosphere, and the
solution was heated at 110 °C for 4 h. Purification by flash column
chromatography (pentane/Et2O 9:1) provided product 5g (33 mg,
72%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 8.12−8.06 (m,
2H), 7.57−7.44 (m, 4H), 7.31 (d, J = 8.2 Hz, 1H), 7.20 (dd, J = 8.2,
2.3 Hz, 1H), 3.79 (s, 3H), 3.53 (s, 3H), 3.42 (d, J = 14.3 Hz, 1H), 3.32
(dd, J = 12.4, 7.7 Hz, 1H), 2.68 (dd, J = 13.8, 7.7 Hz, 1H), 2.50 (d, J =
14.4 Hz, 1H), 2.10 (dd, J = 13.8, 12.4 Hz, 1H), 1.18 (s, 3H) ppm. 13C
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NMR (126 MHz, CDCl3) δ 173.2, 171.3, 167.3, 143.7, 138.2, 133.0,
131.2, 130.3, 128.8, 128.4, 127.6, 127.1, 127.0, 58.4, 53.3, 53.0, 46.7,
46.4, 44.4, 38.9, 28.6 ppm. HRMS-ESI calcd for C23H23ClNO4
+ [M +
H]+: 412.1310; found: 412.1320.
Dimethyl 3-Methylene-4-(phenyl((2-((trimethylsilyl)ethynyl)-
phenyl)amino)methyl)cyclopentane-1,1-dicarboxylate (6e). A dry
10 mL MW vial was charged with PdCl2(PPh3)2 (56 mg, 0.079 mmol),
CuI (38 mg, 0.20 mmol), and 2-iodoaniline 4e (500 mg, 0.99 mmol),
and the MW vial was sealed and left under argon. Degassed Et3N (7
mL) and degassed DMF (3 mL) were added followed by
trimethylsilylacetylene (0.68 mL, 4.95 mmol, 5 equiv) at 25 °C. The
resulting mixture was stirred at 25 °C for 1.5 h (complete conversion
monitored by GC-MS). The dark brown mixture was partitioned
between water (50 mL) and diethyl ether (20 mL). The aqueous layer
was re-extracted with diethyl ether (2 × 20 mL). The combined
ethereal extracts were dried over sodium sulfate and concentrated. The
title product was obtained after purification by chromatography on
silica gel eluting with pentane/Et2O 9:1 to 4:1 as a pale brown
crystalline solid (451 mg, 96%). 1H NMR (500 MHz, CDCl3) δ 7.38−
7.22 (m, 6H), 6.99 (ddd, J = 8.6, 7.4, 1.6 Hz, 1H), 6.56 (td, J = 7.5, 1.0
Hz, 1H), 6.30 (d, J = 8.3 Hz, 1H), 5.14 (d, J = 4.9 Hz, 1H), 5.08 (q, J
= 2.6 Hz, 1H), 4.72 (q, J = 2.5 Hz, 1H), 4.51 (t, J = 5.4 Hz, 1H), 3.70
(s, 3H), 3.70 (s, 3H), 3.18−3.10 (m, 1H), 3.04 (dq, J = 16.4, 1.6 Hz,
1H), 2.95 (dq, J = 16.5, 2.6 Hz, 1H), 2.43 (ddd, J = 13.6, 7.8, 1.7 Hz,
1H), 2.22 (dd, J = 13.5, 10.4 Hz, 1H), 0.30 (s, 9H) ppm. 13C NMR
(126 MHz, CDCl3) δ 171.7, 171.4, 148.6, 146.6, 141.5, 132.1, 129.9,
128.5, 127.2, 126.9, 116.6, 111.1, 110.0, 108.0, 102.0, 100.2, 59.8, 58.0,
52.8, 52.7, 49.3, 41.8, 35.4, − 0.1 ppm. HRMS-ESI calcd for
C28H34NO4Si
+ [M + H]+: 476.2252; found: 476.2247. Mp 108−109
°C.
Dimethyl 3-(((4-Bromo-2-((trimethylsilyl)ethynyl)phenyl)amino)-
(phenyl)methyl)-4-methylenecyclopentane-1,1-dicarboxylate (6f).
Prepared according to the procedure for 6e, with 4f (440 mg, 0.753
mmol), PdCl2(PPh3)2 (42 mg, 0.06 mmol), and CuI (29 mg, 0.15
mmol) in degassed DFM/Et3N (1:2, 6.75 mL) to which was added
TMS-acetylene (208 μL, 1.51 mmol, 2 equiv), followed by stirring at
25 °C for 1.5 h. Obtained as a pale yellow oil after purification by
column chromatography on silica gel eluting with pentane/Et2O 9:1 to
4:1 (400 mg, 96%). 1H NMR (500 MHz, CDCl3) δ 7.38−7.31 (m,
4H), 7.30−7.24 (m, 1H), 7.19 (d, J = 8.2 Hz, 1H), 6.53 (dd, J = 8.2,
2.0 Hz, 1H), 6.29 (d, J = 1.9 Hz, 1H), 5.19 (d, J = 5.3 Hz, 1H), 5.07
(dq, J = 2.5, 1.5 Hz, 1H), 4.71−4.68 (m, 1H), 4.48 (t, J = 5.6 Hz, 1H),
3.70 (s, 3H), 3.69 (s, 3H), 3.19−3.09 (m, 1H), 3.02 (dq, J = 16.4, 1.6
Hz, 1H), 2.91 (dq, J = 16.5, 2.6 Hz, 1H), 2.43 (ddd, J = 13.5, 7.8, 1.7
Hz, 1H), 2.16 (dd, J = 13.5, 10.4 Hz, 1H), 0.31 (s, 9H) ppm. 13C
NMR (126 MHz, CDCl3) δ 171.7, 171.4, 149.4, 146.5, 140.7, 135.7,
132.9, 128.6, 127.5, 126.8, 116.7, 111.1, 110.2, 106.6, 101.2, 100.9,
59.7, 58.0, 52.8, 52,8, 49.1, 41.8, 35.8, 0.0 ppm. HRMS-ESI calcd for
C28H32BrNO4SiNa
+ [M + Na]+: 576.1176; found: 576.1196.
Dimethyl 3-(((4-Chloro-2-((trimethylsilyl)ethynyl)phenyl)amino)-
(phenyl)methyl)-4-methylenecyclopentane-1,1-dicarboxylate (6g).
Prepared according to the procedure for 6e, with 4g (550 mg, 1.02
mmol), PdCl2(PPh3)2 (57.2 mg, 0.08 mmol), CuI (39 mg, 0.20 mmol)
in degassed DFM/Et3N (1:2, 7.5 mL) to which was added TMS-
acetylene (282 μL, 2.04 mmol, 2 equiv), followed by stirring at 25 °C
for 1.5 h. Obtained as a yellow oil after purification by column
chromatography on silica gel eluting with pentane/Et2O 9:1 to 4:1
(502 mg, 97%). 1H NMR (500 MHz, CDCl3) δ 7.39 (d, J = 2.4 Hz,
1H), 7.36−7.30 (m, 4H), 7.28−7.23 (m, 1H), 7.05 (dd, J = 8.8, 2.3
Hz, 1H), 6.16 (d, J = 8.8 Hz, 1H), 5.11 (d, J = 4.8 Hz, 1H), 5.08 (q, J
= 2.5 Hz, 1H), 4.71 (q, J = 2.5 Hz, 1H), 4.47 (t, J = 5.3 Hz, 1H), 3.70
(s, 3H), 3.69 (s, 3H), 3.13 (dddd, J = 10.4, 8.0, 5.6, 2.3 Hz, 1H), 3.03
(dq, J = 16.5, 1.6 Hz, 1H), 2.92 (dq, J = 16.5, 2.6 Hz, 1H), 2.40 (ddd, J
= 13.6, 7.8, 1.7 Hz, 1H), 2.18 (dd, J = 13.5, 10.5 Hz, 1H), 0.30 (s, 9H)
ppm. 13C NMR (126 MHz, CDCl3) δ 171.7, 171.4, 147.5, 146.5,
140.9, 134.2, 132.5, 128.6, 127.4, 126.8, 112.7, 110.1, 110.0, 107.8,
101.7, 100.3, 59.8, 58.0, 52.8, 52,8, 49.2, 41.8, 35.7, 0.0 ppm. HRMS-
ESI calcd for C28H32ClNO4SiNa
+ [M + Na]+: 532.1681; found:
532.1693.
Dimethyl 3-(((2-Ethynylphenyl)amino)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (7e). Substrate 6e (150
mg, 0.32 mmol) was suspended in methanol (1 mL) at 25 °C, and
K2CO3 (131 mg, 0.95 mmol) was added. The mixture was stirred
vigorously at 25 °C for 3 h (disappearance of starting material
monitored by GC-MS). The volatiles were then removed under a
stream of nitrogen, and the residue was purified by column
chromatography on silica gel eluting with pentane/Et2O 4:1 to afford
120 mg of colorless oil (94%). Note: alternatively the deprotection of
the TMS group can be carried out on the crude mixture after
Sonogashira coupling to afford the title alkyne in 81% yield over 2
steps (1 g scale of iodoaniline substrate [1.98 mmol], 650 mg [1.61
mmol] of alkyne obtained). 1H NMR (500 MHz, CDCl3) δ 7.38−7.29
(m, 5H), 7.27−7.22 (m, 1H), 7.03 (ddd, J = 8.6, 7.4, 1.6 Hz, 1H), 6.58
(td, J = 7.5, 1.0 Hz, 1H), 6.31 (d, J = 8.4 Hz, 1H), 5.14 (d, J = 5.1 Hz,
1H), 5.07 (q, J = 2.1 Hz, 1H), 4.73 (q, J = 2.1 Hz, 1H), 4.55 (t, J = 5.4
Hz, 1H), 3.72 (s, 3H), 3.70 (s, 3H), 3.52 (s, 1H), 3.22−3.13 (m, 1H),
3.08−2.96 (m, 2H), 2.45 (dd, J = 13.7, 8.2 Hz, 1H), 2.26 (dd, J = 13.7,
9.9 Hz, 1H) ppm. 13C NMR (126 MHz, CDCl3) δ 171.8, 171.7, 148.8,
147.0, 141.4, 132.3, 130.1, 128.5, 127.2, 126.8, 116.5, 111.0, 110.0,
106.8, 83.2, 80.7, 60.0, 58.2, 52.8, 49.3, 42.1, 35.4 ppm. HRMS-ESI
calcd for C25H25NO4Na
+ [M + Na]+: 426.1676; found: 426.1681.
Dimethyl 3-(((4-Bromo-2-ethynylphenyl)amino)(phenyl)methyl)-
4-methylenecyclopentane-1,1-dicarboxylate (7f). Prepared accord-
ing to the procedure for 7e, with 6f (115 mg, 0.21 mmol) and K2CO3
(86 mg, 0.62 mmol) in methanol (0.7 mL), followed by stirring at 25
°C for 1.5 h. Obtained as a colorless oil after purification by column
chromatography on silica gel eluting with pentane/Et2O 9:1 to 4:1 (72
mg, 72%). 1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 2.4 Hz, 1H),
7.35−7.29 (m, 4H), 7.27−7.23 (m, 1H), 7.09 (dd, J = 8.8, 2.4 Hz,
1H), 6.17 (d, J = 8.9 Hz, 1H), 5.13 (d, J = 5.1 Hz, 1H), 5.07 (q, J = 2.1
Hz, 1H), 4.71 (q, J = 2.1 Hz, 1H), 4.49 (t, J = 5.4 Hz, 1H), 3.72 (s,
3H), 3.70 (s, 3H), 3.54 (s, 1H), 3.19−3.12 (m, 1H), 3.05−2.95 (m,
2H), 2.42 (dd, J = 13.7, 8.2 Hz, 1H), 2.21 (dd, J = 13.8, 9.8 Hz, 1H)
ppm. 13C NMR (126 MHz, CDCl3) δ 171.7, 171.7, 147.8, 146.9,
140.9, 134.4, 132.9, 128.6, 127.4, 126.7, 112.6, 110.0, 108.7, 107.7,
84.3, 79.2, 60.0, 58.1, 52.9, 52.8, 49.2, 42.2, 35.4 ppm. HRMS-ESI
calcd for C25H24BrNO4Na
+ [M + Na]+: 504.0781; found: 504.0778.
Dimethyl 3-(((4-Chloro-2-ethynylphenyl)amino)(phenyl)methyl)-
4-methylenecyclopentane-1,1-dicarboxylate (7g). Prepared accord-
ing to the procedure for 7e, with 6g (135 mg, 0.27 mmol) and K2CO3
(110 mg, 0.79 mmol) in methanol (1 mL), followed by stirring at 25
°C for 2.5 h. Obtained as a pale yellow oil after purification by column
chromatography on silica gel eluting with pentane/Et2O 9:1 to 4:1 (78
mg, 67%). 1H NMR (500 MHz, CDCl3) δ 7.36−7.31 (m, 4H), 7.29−
7.24 (m, 1H), 7.22 (d, J = 8.1 Hz, 1H), 6.55 (dd, J = 8.2, 2.0 Hz, 1H),
6.29 (d, J = 1.9 Hz, 1H), 5.21 (d, J = 5.5 Hz, 1H), 5.07 (q, J = 2.1 Hz,
1H), 4.71 (q, J = 2.1 Hz, 1H), 4.51 (t, J = 5.6 Hz, 1H), 3.72 (s, 3H),
3.70 (s, 3H), 3.54 (s, 1H), 3.20−3.12 (m, 1H), 3.04−2.94 (m, 2H),
2.44 (dd, J = 13.7, 8.3 Hz, 1H), 2.20 (dd, J = 13.8, 9.8 Hz, 1H) ppm.
13C NMR (126 MHz, CDCl3) δ 171.7, 171.7, 149.6, 146.8, 140.6,
136.0, 133.1, 128.7, 127.5, 126.7, 116.7, 111.0, 110.1, 105.3, 84.0, 79.8,
59.9, 58.2, 52.8, 49.2, 42.2, 35.4 ppm. HRMS-ESI calcd for
C25H24ClNO4Na
+ [M + Na]+: 460.1286; found: 460.1286.
Dimethyl 3-((1H-Indol-1-yl)(phenyl)methyl)-4-methylenecyclo-
pentane-1,1-dicarboxylate (8e). In a dry vial, 7e (100 mg, 0.25
mmol) was dissolved in dry CH2Cl2 (2.5 mL) and IPrAuNTf2 (D2)
(10.7 mg, 12 μmol) was added in one portion. The mixture was stirred
at 25 °C for 8 h (monitored by GC-MS). The solvent was removed
under a stream of nitrogen, and the crude mixture was loaded on silica
gel and purified by column chromatography on silica gel eluting with
pentane/Et2O 9:1 to 4:1 to afford the title product as a colorless solid
(78 mg, 78%). 1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 7.9 Hz,
1H), 7.47−7.42 (m, 2H), 7.40−7.34 (m, 2H), 7.32−7.18 (m, 4H),
7.09 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 6.60 (d, J = 3.2 Hz, 1H), 5.29 (d, J
= 11.0 Hz, 1H), 4.90 (q, J = 2.0 Hz, 1H), 4.18−4.14 (m, 1H), 3.87−
3.78 (m, 1H), 3.75 (s, 3H), 3.63 (s, 3H), 3.23 (dq, J = 16.3, 2.4 Hz,
1H), 2.97 (dq, J = 16.3, 1.5 Hz, 1H), 2.66 (ddd, J = 13.9, 7.9, 1.6 Hz,
1H), 1.88 (dd, J = 13.8, 8.2 Hz, 1H) ppm. 13C NMR (126 MHz,
CDCl3) δ 171.9, 171.7, 146.7, 139.8, 136.4, 128.4, 128.3, 127.8, 127.6,
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.5b02607
J. Org. Chem. 2016, 81, 1839−1849
1847
124.6, 121.7, 120.9, 119.6, 111.6, 109.7, 102.5, 63.4, 58.1, 52.9, 52.8,
46.3, 41.7, 38.4 ppm. HRMS-ESI calcd for C25H26NO4
+ [M + H]+:
404.1856; found: 404.1853. Mp 52−54 °C.
Dimethyl 3-((5-Bromo-1H-indol-1-yl)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (8f). Prepared according
to the procedure for 8e, with 7f (61 mg, 0.13 mmol) and IPrAuNTf2
(D2) (5.5 mg, 6.3 μmol) in CH2Cl2 (1.2 mL), followed by stirring at
25 °C for 8 h. Obtained as a colorless foamy solid after purification by
column chromatography on silica gel eluting with pentane/Et2O 9:1 to
4:1 (47 mg, 77%). 1H NMR (500 MHz, CDCl3) δ 7.71 (d, J = 1.6 Hz,
1H), 7.40 (d, J = 3.3 Hz, 1H), 7.34−7.21 (m, 7H), 6.51 (d, J = 3.5 Hz,
1H), 5.22 (d, J = 10.9 Hz, 1H), 4.89 (q, J = 1.9 Hz, 1H), 4.16 (q, J =
1.7 Hz, 1H), 3.81−3.74 (m, 1H), 3.73 (s, 3H), 3.63 (s, 3H), 3.19 (dq,
J = 16.3, 2.3 Hz, 1H), 2.96 (dq, J = 16.4, 1.5 Hz, 1H), 2.59 (ddd, J =
13.8, 7.9, 1.5 Hz, 1H), 1.84 (dd, J = 13.8, 8.2 Hz, 1H) ppm. 13C NMR
(126 MHz, CDCl3) δ 171.8, 171.7, 146.6, 139.4, 135.0, 130.0, 128.6,
128.1, 127.5, 125.9, 124.5, 123.4, 112.9, 111.7, 111.2, 102.1, 63.7, 58.0,
52.9, 52.9, 46.3, 41.6, 38.3 ppm. HRMS-ESI calcd for C25H25BrNO4
+
[M + H]+: 482.0961; found: 482.0959. Mp 55−56 °C.
Dimethyl 3-((5-Chloro-1H-indol-1-yl)(phenyl)methyl)-4-
methylenecyclopentane-1,1-dicarboxylate (8g). Prepared according
to the procedure for 8e, with 7g (62 mg, 0.14 mmol) and IPrAuNTf2
(D2) (6.1 mg, 7.1 μmol) in CH2Cl2 (1.3 mL), followed by stirring at
25 °C for 8 h. Obtained as a colorless foamy solid after purification by
column chromatography on silica gel eluting with pentane/Et2O 9:1 to
4:1 (42 mg, 68%). 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.4 Hz,
1H), 7.41−7.39 (m, 2H), 7.36−7.33 (m, 2H), 7.32−7.28 (m, 2H),
7.27−7.22 (m, 1H), 7.04 (dd, J = 8.4, 1.8 Hz, 1H), 6.55 (dd, J = 3.3,
1.8 Hz, 1H), 5.18 (d, J = 11.0 Hz, 1H), 4.89 (q, J = 2.0 Hz, 1H), 4.14
(dd, J = 2.7, 1.5 Hz, 1H), 3.81−3.75 (m, 1H), 3.74 (s, 3H), 3.64 (s,
3H), 3.20 (dq, J = 16.4, 2.4 Hz, 1H), 2.96 (dq, J = 16.3, 1.5 Hz, 1H),
2.61 (ddd, J = 13.8, 7.9, 1.6 Hz, 1H), 1.83 (dd, J = 13.8, 8.2 Hz, 1H)
ppm. 13C NMR (126 MHz, CDCl3) δ 171.8, 171.6, 146.5, 139.4,
136.8, 128.6, 128.1, 127.8, 127.6, 126.8, 125.3, 121.7, 120.3, 111.7,
109.7, 102.8, 63.6, 58.1, 52.9, 52.9, 46.3, 41.6, 38.3 ppm. HRMS-ESI
calcd for C25H24ClNO4Na
+ [M + Na]+: 460.1286; found: 460.1281.
Mp 49−50 °C.
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Echavarren, A. M. J. Am. Chem. Soc. 2001, 123, 10511−10520.
(b) Michelet, V.; Charruault, L.; Gladiali, S.; Genet̂, J. P. Pure Appl.
Chem. 2006, 78, 397−407 and references therein. (c) Nevado, C.;
Charruault, L.; Michelet, V.; Nieto-Oberhuber, C.; Muñoz, M. P.;
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